AURB
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A1L429 | S7 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| A6NDE8 | S7 | Sugiyama | GAGE12H | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| A6NER3 | S7 | Sugiyama | GAGE12J | ______________MSWRGRsTyyWPRPRPYVQPPEMIGPM |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| O00458 | S15 | Sugiyama | IFRD1 | ______MPKNKKRNtPHRGssAGGGGsGAAAATAATAGGQH |
| O00458 | T9 | Sugiyama | IFRD1 | ____________MPKNKKRNtPHRGssAGGGGsGAAAATAA |
| O00469 | S600 | Sugiyama | PLOD2 | VEEMEHyGKWSGGKHHDsRIsGGyENVPTDDIHMKQVDLEN |
| O00562 | S664 | Sugiyama | PITPNM1 DRES9 NIR2 PITPNM | SQNSLQAAPATTSSWEPRRAstAFCPPAASSEAPDGPSSTA |
| O00566 | T332 | EPSD|PSP | MPHOSPH10 MPP10 | DDDLQENEDNKQHKESLKRVtFALPDDAETEDTGVLNVKKN |
| O00571 | S594 | EPSD|PSP|Sugiyama | DDX3X DBX DDX3 | MAyEHHyKGssRGRSKssRFsGGFGARDYRQssGAssssFs |
| O00571 | S605 | Sugiyama | DDX3X DBX DDX3 | RGRSKssRFsGGFGARDYRQssGAssssFsssRAsSsRSGG |
| O00571 | S82 | Sugiyama | DDX3X DBX DDX3 | ssKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRs |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14641 | S651 | Sugiyama | DVL2 | LRRGGEAsGtsDGGPPPsRGstGGAPNLRAHPGLHPYGPPP |
| O14777 | S15 | SIGNOR|EPSD|PSP | NDC80 HEC HEC1 KNTC2 | ______MKRSsVsSGGAGRLsMQELRSQDVNKQGLYtPQTK |
| O14777 | S44 | SIGNOR|EPSD|PSP | NDC80 HEC HEC1 KNTC2 | VNKQGLYtPQTKEKPTFGKLsINKPtsERKVsLFGKRtsGH |
| O14777 | S5 | SIGNOR|EPSD|PSP | NDC80 HEC HEC1 KNTC2 | ________________MKRSsVsSGGAGRLsMQELRSQDVN |
| O14777 | S55 | EPSD|PSP | NDC80 HEC HEC1 KNTC2 | KEKPTFGKLsINKPtsERKVsLFGKRtsGHGsRNsQLGIFs |
| O14777 | S69 | EPSD|PSP | NDC80 HEC HEC1 KNTC2 | tsERKVsLFGKRtsGHGsRNsQLGIFsssEKIKDPRPLNDK |
| O14777 | T49 | EPSD|PSP | NDC80 HEC HEC1 KNTC2 | LYtPQTKEKPTFGKLsINKPtsERKVsLFGKRtsGHGsRNs |
| O14950 | S20 | EPSD|PSP | MYL12B MRLC2 MYLC2B | _MSSKKAKTKTTKKRPQRAtsNVFAMFDQSQIQEFKEAFNM |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15392 | T117 | SIGNOR|ELM|EPSD|PSP | BIRC5 API4 IAP4 | TLGEFLKLDRERAKNKIAKEtNNKKKEFEETAKKVRRAIEQ |
| O15392 | T34 | EPSD|PSP | BIRC5 API4 IAP4 | LKDHRIstFKNWPFLEGCACtPERMAEAGFIHCPtENEPDL |
| O15523 | S592 | EPSD|PSP|Sugiyama | DDX3Y DBY | MAyEHHyKGGSRGRSKSNRFsGGFGARDYRQSSGSSSSGFG |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43823 | S124 | Sugiyama | AKAP8 AKAP95 | SKEGGRGGsGGGGEGIQDREssFRFQPFESYDSRPCLPEHN |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O60716 | Y865 | Sugiyama | CTNND1 KIAA0384 | KKsDFQVNLNNAsRsQssHsyDDstLPLIDRNQKsDKKPDR |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60814 | S79 | EPSD | H2BC12 H2BFT HIRIP1 HIST1H2BK | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y84 | EPSD | H2BC12 H2BFT HIRIP1 HIST1H2BK | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | T78 | Sugiyama | EIF5B IF2 KIAA0741 | ILKELEELsLEAQGIKADREtVAVKPTENNEEEFtsKDKKK |
| O60879 | S196 | SIGNOR | DIAPH2 DIA | DEKLLNCLESLRVSLTSNPVsWVNNFGHEGLGLLLDELEKL |
| O75157 | S205 | Sugiyama | TSC22D2 KIAA0669 TILZ4 | yYERDSDSSVLTRSGDCIRHssTFDQTAERDSGLGATGGSV |
| O75348 | T71 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | REKEFKAKEAAALGsRGsCstEVEKETQEKMTILQtyFRQN |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O75821 | S28 | Sugiyama | EIF3G EIF3S4 | sKPsWADQVEEEGEDDKCVtsELLKGIPLAtGDtsPEPELL |
| O76021 | T312 | EPSD|PSP | RSL1D1 CATX11 CSIG PBK1 L12 | RERNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKK |
| O76087 | S7 | Sugiyama | GAGE7 GAGE12I GAGE7B | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| O94763 | S188 | Sugiyama | URI1 C19orf2 NNX3 PPP1R19 RMP URI | DFEFKAKHRIAHKPHSKPKTsDIFEADIANDVKSKDLLADK |
| O95229 | S250 | SIGNOR|PSP | ZWINT | AEAENLPDDKPQQPTRPQEQstGDTMGRDPGVsFKAVGLQP |
| O95229 | S262 | SIGNOR|PSP | ZWINT | QPTRPQEQstGDTMGRDPGVsFKAVGLQPAGDVNLP_____ |
| O95229 | T251 | SIGNOR|PSP | ZWINT | EAENLPDDKPQQPTRPQEQstGDTMGRDPGVsFKAVGLQPA |
| O95235 | S878 | SIGNOR|EPSD|PSP | KIF20A MKLP2 RAB6KIFL | PtCQSStDCsPyARILRSRRsPLLKsGPFGKKY________ |
| O95239 | S801 | PSP | KIF4A KIF4 | LKEKKESGENPPPKLRRRtFsLtEVRGQVsEsEDsItKQIE |
| O95239 | T799 | SIGNOR|EPSD|PSP | KIF4A KIF4 | AQLKEKKESGENPPPKLRRRtFsLtEVRGQVsEsEDsItKQ |
| O95456 | S180 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | KNMQITILTCRHVTDYKTSEsTGsLPsPFLRALKTQNFKDS |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| O95817 | S195 | Sugiyama | BAG3 BIS | AAsDCsssSsSAsLPssGRssLGsHQLPRGyISIPVIHEQN |
| O95817 | S284 | Sugiyama | BAG3 BIS | sPFRssVQGAssREGsPARsstPLHsPsPIRVHtVVDRPQQ |
| O95831 | S100 | Sugiyama | AIFM1 AIF PDCD8 | AGAYAYKTMKEDEKRyNERIsGLGLtPEQKQKKAALsAsEG |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00491 | S163 | Sugiyama | PNP NP | GQNPLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGE |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S174 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | LSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKEL |
| P00558 | S175 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | SKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGFLMKKELN |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P02545 | S437 | Sugiyama | LMNA LMN1 | KKRKLEstEsRssFsQHARtsGRVAVEEVDEEGKFVRLRNK |
| P02545 | T436 | Sugiyama | LMNA LMN1 | tKKRKLEstEsRssFsQHARtsGRVAVEEVDEEGKFVRLRN |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04083 | S170 | Sugiyama | ANXA1 ANX1 LPC1 | RDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsE |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | S182 | Sugiyama | ANXA1 ANX1 LPC1 | RDLAKDItsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsD |
| P04083 | S189 | Sugiyama | ANXA1 ANX1 LPC1 | tsDtsGDFRNALLsLAKGDRsEDFGVNEDLADsDARALyEA |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04637 | S183 | SIGNOR|EPSD|PSP | TP53 P53 | YKQSQHMTEVVRRCPHHERCsDsDGLAPPQHLIRVEGNLRV |
| P04637 | S215 | SIGNOR|EPSD|PSP | TP53 P53 | IRVEGNLRVEYLDDRNtFRHsVVVPyEPPEVGSDCTTIHYN |
| P04637 | S269 | SIGNOR|EPSD|PSP | TP53 P53 | RPILTIITLEDSSGNLLGRNsFEVRVCACPGRDRRtEEENL |
| P04637 | T211 | SIGNOR|EPSD|PSP | TP53 P53 | PQHLIRVEGNLRVEYLDDRNtFRHsVVVPyEPPEVGSDCTT |
| P04637 | T284 | SIGNOR|EPSD|PSP | TP53 P53 | LLGRNsFEVRVCACPGRDRRtEEENLRKKGEPHHELPPGSt |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05204 | S25 | EPSD|PSP | HMGN2 HMG17 | KAEGDAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAP |
| P05204 | S29 | EPSD|PSP | HMGN2 HMG17 | DAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAPAKKG |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P05787 | T6 | EPSD|PSP | KRT8 CYK8 | _______________MSIRVtQKsYKVSTSGPRAFSSRsYT |
| P06400 | S780 | EPSD|PSP | RB1 | FMQRLKtNILQyAstRPPtLsPIPHIPRsPyKFPssPLRIP |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06748 | S125 | PSP | NPM1 NPM | GsGPVHIsGQHLVAVEEDAEsEDEEEEDVKLLsIsGKRsAP |
| P06899 | S79 | EPSD | H2BC11 H2BFR HIST1H2BJ | AMGIMNSFVNDIFERIAGEAsRLAHyNKRSTITSREIQTAV |
| P06899 | Y84 | EPSD | H2BC11 H2BFR HIST1H2BJ | NSFVNDIFERIAGEAsRLAHyNKRSTITSREIQTAVRLLLP |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07384 | S474 | Sugiyama | CAPN1 CANPL1 PIG30 | GQPAVHLKRDFFLANAsRARsEQFINLREVSTRFRLPPGEY |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07814 | S1511 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PGAKCVCGKNPAKyytLFGRsy___________________ |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T1506 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | LCELQPGAKCVCGKNPAKyytLFGRsy______________ |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08174 | S54 | Sugiyama | CD55 CR DAF | GDCGLPPDVPNAQPALEGRTsFPEDtVItyKCEEsFVKIPG |
| P08238 | S255 | EPSD|PSP | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEKEEEDKDDEEKPKIEDVGsDEEDDsGKDKKKKTKKIKEK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S452 | EPSD|PSP|Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S470 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEs |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08670 | S72 | EPSD | VIM | LyAssPGGVyAtRssAVRLRssVPGVRLLQDsVDFsLADAI |
| P08670 | S73 | SIGNOR|ELM|EPSD|PSP | VIM | yAssPGGVyAtRssAVRLRssVPGVRLLQDsVDFsLADAIN |
| P08865 | S75 | Sugiyama | RPSA LAMBR LAMR1 | WEKLLLAARAIVAIENPADVsVIssRNtGQRAVLKFAAAtG |
| P08865 | T82 | Sugiyama | RPSA LAMBR LAMR1 | ARAIVAIENPADVsVIssRNtGQRAVLKFAAAtGAtPIAGR |
| P09525 | T127 | Sugiyama | ANXA4 ANX4 | GCLIEILASRTPEEIRRIsQtYQQQYGRSLEDDIRSDTSFM |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0CL80 | S7 | Sugiyama | GAGE12F | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| P0DSO3 | S7 | Sugiyama | GAGE4 | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| P10412 | S27 | SIGNOR | H1-4 H1F4 HIST1H1E | AAPAAPAPAEKtPVKKKARKsAGAAKRKAsGPPVsELItKA |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S41 | Sugiyama | H1-4 H1F4 HIST1H1E | KKKARKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11940 | S51 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | FSPAGPILsIRVCRDMITRRsLGyAyVNFQQPADAERALDt |
| P12277 | T322 | Sugiyama | CKB CKBB | LGKHEKFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRL |
| P12277 | T327 | Sugiyama | CKB CKBB | KFsEVLKRLRLQKRGtGGVDtAAVGGVFDVsNADRLGFSEV |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13807 | S710 | Sugiyama | GYS1 GYS | APEWPRRAsCTsSTSGSKRNsVDtAtsssLstPsEPLsPts |
| P13861 | S58 | Sugiyama | PRKAR2A PKR2 PRKAR2 | TRLREARAPAsVLPAAtPRQsLGHPPPEPGPDRVADAKGDs |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14136 | S13 | SIGNOR|ELM|EPSD|PSP | GFAP | ________MERRRItsAARRsYVssGEMMVGGLAPGRRLGP |
| P14136 | S38 | SIGNOR|ELM|EPSD|PSP | GFAP | GEMMVGGLAPGRRLGPGTRLsLARMPPPLPTRVDFSLAGAL |
| P14136 | T7 | SIGNOR|ELM|EPSD|PSP | GFAP | ______________MERRRItsAARRsYVssGEMMVGGLAP |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S346 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | CAtQMLEsMIKKPRPTRAEGsDVANAVLDGADCIMLSGEtA |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14618 | T45 | PSP|Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T95 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTK |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14866 | S543 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | ELGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLN |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15408 | S309 | Sugiyama | FOSL2 FRA2 | EQESPASPSESCSKAHRRssssGDQssDsLNsPtLLAL___ |
| P15408 | S310 | Sugiyama | FOSL2 FRA2 | QESPASPSESCSKAHRRssssGDQssDsLNsPtLLAL____ |
| P16070 | S43 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLNITCRFAGVFHVEKNGRYsIsRtEAADLCKAFNSTLPTM |
| P16070 | S71 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | DLCKAFNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRI |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S42 | Sugiyama | H1-3 H1F3 HIST1H1D | KKAKKAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17661 | S12 | SIGNOR|ELM|iPTMNet|EPSD|PSP | DES | _________MSQAYSSsQRVssYRRtFGGAPGFPLGsPLss |
| P17661 | S60 | SIGNOR|ELM|iPTMNet|EPSD|PSP | DES | FGsKGssssVTSRVYQVSRtsGGAGGLGsLRAsRLGttRtP |
| P17661 | T17 | SIGNOR|ELM|EPSD|PSP | DES | ____MSQAYSSsQRVssYRRtFGGAPGFPLGsPLssPVFPR |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18615 | S131 | EPSD|PSP | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19174 | S1233 | Sugiyama | PLCG1 PLC1 | PAKENGDLsPFsGtsLRERGsDASGQLFHGRAREGsFEsRy |
| P19338 | S328 | Sugiyama | NCL | NLFVGNLNFNKSAPELKtGIsDVFAKNDLAVVDVRIGMTRK |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22626 | S201 | Sugiyama | HNRNPA2B1 HNRPA2B1 | NAEVRKALsRQEMQEVQssRsGRGGNFGFGDsRGGGGNFGP |
| P23142 | S247 | Sugiyama | FBLN1 PP213 | CRLGESCINTVGSFRCQRDssCGtGYELTEDNSCKDIDECE |
| P23527 | S79 | EPSD | H2BC17 H2BFH H2BFN HIST1H2BO | AMGIMNSFVNDIFERIAGEAsRLAHyNKRSTITSREIQTAV |
| P23527 | Y84 | EPSD | H2BC17 H2BFH H2BFN HIST1H2BO | NSFVNDIFERIAGEAsRLAHyNKRSTITSREIQTAVRLLLP |
| P23921 | S780 | Sugiyama | RRM1 RR1 | KEKVSKEEEEKERNtAAMVCsLENRDECLMCGS________ |
| P23921 | T774 | Sugiyama | RRM1 RR1 | KEKLKDKEKVSKEEEEKERNtAAMVCsLENRDECLMCGS__ |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25398 | S107 | Sugiyama | RPS12 | EWVGLCKIDREGKPRKVVGCsCVVVKDYGKESQAKDVIEEy |
| P25490 | S180 | SIGNOR | YY1 INO80S | GGGGSSSSGGGRVKKGGGKKsGKKsYLsGGAGAAGGGGADP |
| P25490 | S184 | SIGNOR|EPSD|PSP | YY1 INO80S | SSSSGGGRVKKGGGKKsGKKsYLsGGAGAAGGGGADPGNKK |
| P25786 | S211 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | GLRALRETLPAEQDLttKNVsIGIVGKDLEFTIyDDDDVsP |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25963 | S262 | PSP | NFKBIA IKBA MAD3 NFKBI | DVNRVTYQGYSPYQLTWGRPsTRIQQQLGQLTLENLQMLPE |
| P25963 | S32 | PSP | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S63 | PSP | NFKBIA IKBA MAD3 NFKBI | EQMVKELQEIRLEPQEVPRGsEPWKQQLTEDGDSFLHLAII |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | S129 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | QELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDE |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P28066 | S174 | Sugiyama | PSMA5 | FHMDPsGtFVQCDARAIGsAsEGAQssLQEVyHKSMTLKEA |
| P28074 | S229 | Sugiyama | PSMB5 LMPX MB1 X | EQAyDLARRAIyQATYRDAysGGAVNLyHVREDGWIRVSsD |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P30044 | S182 | Sugiyama | PRDX5 ACR1 SBBI10 | DLLLDDsLVsIFGNRRLKRFsMVVQDGIVKALNVEPDGTGL |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30101 | S98 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | VPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGP |
| P30520 | S448 | Sugiyama | ADSS2 ADSS | yVRFIEDELQIPVKWIGVGKsREsMIQLF____________ |
| P30520 | S451 | Sugiyama | ADSS2 ADSS | FIEDELQIPVKWIGVGKsREsMIQLF_______________ |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31939 | S554 | Sugiyama | ATIC PURH OK/SW-cl.86 | VSISSDAFFPFRDNVDRAKRsGVAyIAAPSGsAADKVVIEA |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33778 | S79 | EPSD | H2BC3 H2BFF HIST1H2BB | AMGIMNSFVNDIFERIAGEAsRLAHyNKRSTITSREIQTAV |
| P33778 | Y84 | EPSD | H2BC3 H2BFF HIST1H2BB | NSFVNDIFERIAGEAsRLAHyNKRSTITSREIQTAVRLLLP |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S647 | Sugiyama | HSPA4 APG2 HSPH2 | EMRDKLSGEYEKFVSEDDRNsFtLKLEDTENWLyEDGEDQP |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P35580 | T1847 | PSP | MYH10 | EEQLEQEAKERAAANKLVRRtEKKLKEIFMQVEDERRHADQ |
| P35659 | T67 | EPSD|PSP | DEK | EKEKsLIVEGKREKKKVERLtMQVssLQREPFTIAQGKGQK |
| P36551 | T111 | Sugiyama | CPOX CPO CPX | AAFGHVQRAEMLPKTSGTRAtsLGRPEEEEDELAHRCSSFM |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38159 | S326 | EPSD|PSP | RBMX HNRPG RBMXP1 | GssRYDDysssRDGyGGsRDsysssRsDLYssGRDRVGRQE |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P41091 | S107 | Sugiyama | EIF2S3 EIF2G | KIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLV |
| P42166 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsND |
| P42167 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSND |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45973 | S92 | EPSD|PSP | CBX5 HP1A | KMKEGENNKPREKSESNKRKsNFsNsADDIKSKKKREQsND |
| P46013 | S299 | Sugiyama | MKI67 | GLQGETQLLVSRKSRPKsGGsGHAVAEPAsPEQELDQNKGK |
| P46013 | S374 | EPSD|PSP | MKI67 | QQNsPQKHKNKDLYTtGRREsVNLGKSEGFKAGDKTLTPRK |
| P46013 | S538 | EPSD|PSP | MKI67 | DENLPPNtPLKRGEAPTKRKsLVMHtPPVLKKIIKEQPQPS |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46459 | S207 | Sugiyama | NSF | KAENSSLNLIGKAKTKENRQsIINPDWNFEKMGIGGLDKEF |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46778 | S104 | EPSD|PSP | RPL21 | ILAKRINVRIEHIKHSKSRDsFLKRVKENDQKKKEAKEKGt |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46779 | T89 | Sugiyama | RPL28 | GQRKPAtsyVRttINKNARAtLsSIRHMIRKNKYRPDLRMA |
| P46783 | T118 | EPSD|PSP|Sugiyama | RPS10 | RPETGRPRPKGLEGERPARLtRGEADRDTYRRSAVPPGADK |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P47712 | S729 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | KEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKPKA |
| P48643 | S51 | Sugiyama | CCT5 CCTE KIAA0098 | LEALKSHIMAAKAVANtMRtsLGPNGLDKMMVDKDGDVtVT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49321 | S659 | Sugiyama | NASP | IEELKELLPEIREKIEDAKEsQRsGNVAELALKATLVEsst |
| P49327 | S1997 | Sugiyama | FASN FAS | DGLLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFV |
| P49450 | S7 | SIGNOR|ELM|iPTMNet|EPSD|PSP | CENPA | ______________MGPRRRsRKPEAPRRRsPsPtPtPGPs |
| P49589 | S312 | Sugiyama | CARS1 CARS | GDQKALQEGEGDLsIsADRLsEKRSPNDFALWKASKPGEPS |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P49792 | S786 | Sugiyama | RANBP2 NUP358 | GsLRNADsEIKHstPsPtRYsLsPsKsyKYsPKtPPRWAED |
| P50395 | S396 | Sugiyama | GDI2 RABGDIB | IEQKFVsISDLLVPKDLGtEsQIFIsRTyDAttHFEttCDD |
| P50395 | S427 | Sugiyama | GDI2 RABGDIB | ttHFEttCDDIKNIYKRMtGsEFDFEEMKRKKNDIYGED__ |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51659 | S185 | Sugiyama | HSD17B4 EDH17B4 SDR8C1 | SAAKLGLLGLANSLAIEGRKsNIHCNtIAPNAGsRMTQTVM |
| P51991 | S355 | Sugiyama | HNRNPA3 HNRPA3 | YSGQQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGs |
| P51991 | S356 | Sugiyama | HNRNPA3 HNRPA3 | SGQQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsR |
| P52597 | S54 | Sugiyama | HNRNPF HNRPF | CtIHDGAAGVHFIYTREGRQsGEAFVELGsEDDVKMALKKD |
| P52789 | T409 | Sugiyama | HK2 | TLAAVLQRIKENKGEERLRstIGVDGsVyKKHPHFAKRLHK |
| P52907 | S123 | Sugiyama | CAPZA1 | KEAsDPQPEEADGGLKsWREsCDsALRAYVKDHYSNGFCTV |
| P53350 | T210 | EPSD|PSP | PLK1 PLK | VKIGDFGLATKVEYDGERKKtLCGtPNyIAPEVLSKKGHSF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54578 | S431 | Sugiyama | USP14 TGT | GSNNCGYYDLQAVLTHQGRSssSGHyVSWVKRKQDEWIKFD |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54750 | S345 | Sugiyama | PDE1A | EMVLSTDMSGHFQQIKNIRNsLQQPEGIDRAKTMSLILHAA |
| P55010 | S10 | Sugiyama | EIF5 | ___________MSVNVNRsVsDQFyRyKMPRLIAKVEGKGN |
| P56524 | S265 | SIGNOR | HDAC4 KIAA0288 | AsEPNLKLRSRLKQKVAERRssPLLRRKDGPVVTALKKRPL |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57721 | S158 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | AsQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAV |
| P57721 | S82 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | GKKGETVKKMREESGARINIsEGNCPERIVTITGPTDAIFK |
| P57721 | T159 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | sQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAVT |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P58876 | S79 | EPSD | H2BC5 H2BFB HIRIP2 HIST1H2BD | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y84 | EPSD | H2BC5 H2BFB HIRIP2 HIST1H2BD | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | S43 | Sugiyama | RPL23A | KAKKAVLKGVHSHKKKKIRtsPTFRRPKTLRLRRQPKYPRK |
| P62753 | S53 | Sugiyama | RPS6 OK/SW-cl.2 | AtEVAADALGEEWKGYVVRIsGGNDKQGFPMKQGVLTHGRV |
| P62805 | S48 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | QGItKPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIR |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62807 | S79 | EPSD | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y84 | EPSD | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | EPSD|PSP|Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | S57 | Sugiyama | YWHAZ | sNEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQ |
| P63104 | S58 | Sugiyama | YWHAZ | NEERNLLsVAyKNVVGARRssWRVVssIEQKTEGAEKKQQM |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68431 | S11 | SIGNOR|ELM|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P68431 | S29 | SIGNOR|ELM|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | RKstGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| P68431 | T4 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | _________________MARtKQtARKstGGKAPRKQLATK |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78527 | S511 | EPSD|PSP | PRKDC HYRC HYRC1 | CSKPVVLPKGPEsEsEDHRAsGEVRtGKWKVPTYKDyVDLF |
| P82970 | S20 | EPSD|PSP | HMGN5 NSBP1 | _MPKRKAAGQGDMRQEPKRRsARLsAMLVPVtPEVKPKRTS |
| P82970 | S24 | EPSD|PSP | HMGN5 NSBP1 | RKAAGQGDMRQEPKRRsARLsAMLVPVtPEVKPKRTSSSRK |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84243 | S11 | SIGNOR|ELM|EPSD | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | __________MARtKQTARKstGGKAPRKQLATKAARKsAP |
| P84243 | S29 | ELM|EPSD | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | RKstGGKAPRKQLATKAARKsAPsTGGVKKPHRyRPGtVAL |
| P98082 | S723 | Sugiyama | DAB2 DOC2 | DANQLLNKINEPPKPAPRQVsLPVTKstDNAFENPFFKDsF |
| P98179 | S147 | EPSD|PSP | RBM3 RNPL | yGyGRSRDYNGRNQGGYDRysGGNyRDNyDN__________ |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q00839 | S14 | PSP | HNRNPU C1orf199 HNRPU SAFA U21.1 | _______MsssPVNVKKLKVsELKEELKKRRLsDKGLKAEL |
| Q00839 | S26 | PSP | HNRNPU C1orf199 HNRPU SAFA U21.1 | VNVKKLKVsELKEELKKRRLsDKGLKAELMERLQAALDDEE |
| Q01082 | S1670 | Sugiyama | SPTBN1 SPTB2 | QLSKTSRALVADSHPEsERIsMRQSKVDKLYAGLKDLAEER |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q02241 | S714 | ELM|EPSD | KIF23 KNSL5 MKLP1 | YIAQISNGQQLMSQPQLHRRsNsCssISVASCISEWEQKIP |
| Q02241 | S911 | EPSD|PSP | KIF23 KNSL5 MKLP1 | QFTDIEtLKQEsPNGsRKRRsstVAPAQPDGAEsEWtDVET |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02818 | S369 | Sugiyama | NUCB1 NUC | RFEEELAAREAELNAKAQRLsQETEALGRsQGRLEAQKREL |
| Q04695 | S28 | Sugiyama | KRT17 | FTSSSsIKGSSGLGGGsSRTsCRLsGGLGAGsCRLGSAGGL |
| Q04695 | S32 | Sugiyama | KRT17 | SsIKGSSGLGGGsSRTsCRLsGGLGAGsCRLGSAGGLGSTL |
| Q04837 | S67 | Sugiyama | SSBP1 SSBP | QVEGKNPVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRI |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06210 | S37 | Sugiyama | GFPT1 GFAT GFPT | REILETLIKGLQRLEYRGYDsAGVGFDGGNDKDWEANACKI |
| Q06830 | S30 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | HPAPNFKAtAVMPDGQFKDIsLsDyKGKYVVFFFYPLDFTF |
| Q07021 | S106 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | LsDEIKEERKIQKHKTLPKMsGGWELELNGTEAKLVRKVAG |
| Q07820 | T301 | PSP | MCL1 BCL2L3 | INQESCIEPLAESITDVLVRtKRDWLVKQRGWDGFVEFFHV |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q08211 | S449 | Sugiyama | DHX9 DDX9 LKP NDH2 | FIQNDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSC |
| Q08211 | S452 | Sugiyama | DHX9 DDX9 LKP NDH2 | NDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSCGYS |
| Q08J23 | S139 | SIGNOR|iPTMNet|EPSD|PSP | NSUN2 SAKI TRM4 | SWYPEELAWHTNLSRKILRKsPHLEKFHQFLVSETESGNIS |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09666 | T158 | EPSD|PSP | AHNAK PM227 | GVEGDLGEtQsRTITVTRRVtAytVDVTGREGAKDIDIssP |
| Q12888 | S1342 | SIGNOR|EPSD|PSP | TP53BP1 | sAMHSSGssGKGAGPLRGKtsGtEPADFALPssRGGPGKLs |
| Q12965 | S1009 | Sugiyama | MYO1E MYO1C | yTsMARPPLPRQQstssDRVsQtPEsLDFLKVPDQGAAGVR |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q13069 | S7 | Sugiyama | GAGE5 | ______________MSWRGRsTyyWPRPRRYVQPPEVIGPM |
| Q13070 | S7 | Sugiyama | GAGE6 | ______________MSWRGRsTyyWPRPRRYVQPPEVIGPM |
| Q13112 | S410 | Sugiyama | CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 | LNMRtPDtAKKTKsQtHRGssPGPRPVEGtPASRtQDPssP |
| Q13283 | S67 | Sugiyama | G3BP1 G3BP | sNGKPADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLN |
| Q13283 | T71 | Sugiyama | G3BP1 G3BP | PADAVyGQKEIHRKVMsQNFtNCHTKIRHVDAHATLNDGVV |
| Q13310 | S51 | Sugiyama | PABPC4 APP1 PABP4 | FSPAGPVLsIRVCRDMITRRsLGyAyVNFQQPADAERALDt |
| Q13310 | S96 | Sugiyama | PABPC4 APP1 PABP4 | VIKGKPIRIMWSQRDPsLRKsGVGNVFIKNLDKSIDNKALy |
| Q13315 | S1403 | SIGNOR|EPSD|PSP | ATM | SHVIKATFAYISNCHKTKLKsILEILSKSPDSYQKILLAIC |
| Q13435 | S303 | Sugiyama | SF3B2 SAP145 | RQEEMNsQQEEEEMETDARssLGQsAsEtEEDtVsVsKKEK |
| Q13761 | T14 | EPSD|PSP | RUNX3 AML2 CBFA3 PEBP2A3 | _______MRIPVDPSTSRRFtPPsPAFPCGGGGGKMGENSG |
| Q13761 | T173 | EPSD|PSP | RUNX3 AML2 CBFA3 PEBP2A3 | tItVFTNPTQVATYHRAIKVtVDGPREPRRHRQKLEDQTKP |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1188 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PWRPLVKPGGWREKEKAREEsWGPPRESRPsEEREWDREKE |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14160 | S493 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | RAtPHPSELKVMKRSIEGRRsEACPCQPDsGsPLPAEEEKR |
| Q14432 | S293 | Sugiyama | PDE3A | sQLIAGTKEDIPVFKRRRRsssVVsAEMSGCSSKSHRRtsL |
| Q14432 | S294 | Sugiyama | PDE3A | QLIAGTKEDIPVFKRRRRsssVVsAEMSGCSSKSHRRtsLP |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14697 | S187 | Sugiyama | GANAB G2AN KIAA0088 | LLsVNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRD |
| Q14847 | S146 | Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14847 | Y152 | Sugiyama | LASP1 MLN50 | GPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPtsAPVyQ |
| Q14980 | S1969 | EPSD|PSP | NUMA1 NMP22 NUMA | GTItDEEMKtGDPQETLRRAsMQPIQIAEGTGITTRQQRKR |
| Q14980 | S1991 | Sugiyama | NUMA1 NMP22 NUMA | QPIQIAEGTGITTRQQRKRVsLEPHQGPGtPEsKKATSCFP |
| Q14980 | S2047 | EPSD|PSP | NUMA1 NMP22 NUMA | TTEAQKKAAPASTKQADRRQsMAFsILNtPKKLGNsLLRRG |
| Q14980 | T1811 | EPSD|PSP | NUMA1 NMP22 NUMA | DsLGDVFLDsGRKtRSARRRttQIINITMTKKLDVEEPDsA |
| Q14980 | T2055 | EPSD|PSP | NUMA1 NMP22 NUMA | APASTKQADRRQsMAFsILNtPKKLGNsLLRRGASKKALsK |
| Q15021 | S585 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | ILGLIFKGPAASTQEKNPREstGNMVTGQTVCKNKPNMsDP |
| Q15021 | T586 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | LGLIFKGPAASTQEKNPREstGNMVTGQTVCKNKPNMsDPE |
| Q15084 | S389 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FALLKGsFsEQGINEFLRELsFGRGstAPVGGGAFPtIVER |
| Q15084 | S88 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | AATALKDVVKVGAVDADKHHsLGGQyGVQGFPtIKIFGSNK |
| Q15149 | T2886 | EPSD|PSP | PLEC PLEC1 | LLEAQAASGFLLDPVRNRRLtVNEAVKEGVVGPELHHKLLS |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15365 | S126 | Sugiyama | PCBP1 | ATQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAI |
| Q15365 | S50 | Sugiyama | PCBP1 | GKKGESVKRIREEsGARINIsEGNCPERIItLTGPTNAIFK |
| Q15365 | T127 | Sugiyama | PCBP1 | TQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15366 | S126 | Sugiyama | PCBP2 | AsQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAI |
| Q15366 | S50 | Sugiyama | PCBP2 | GKKGESVKKMREESGARINIsEGNCPERIITLAGPTNAIFK |
| Q15366 | T127 | Sugiyama | PCBP2 | sQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15459 | T474 | Sugiyama | SF3A1 SAP114 | EVyAPGLDIESsLKQLAERRtDIFGVEETAIGKKIGEEEIQ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16695 | S29 | EPSD | H3-4 H3FT HIST3H3 | RKsTGGKAPRKQLATKVARKsAPATGGVKKPHRyRPGtVAL |
| Q16778 | S79 | EPSD | H2BC21 H2BFQ HIST2H2BE | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| Q16778 | Y84 | EPSD | H2BC21 H2BFQ HIST2H2BE | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| Q17R91 | S196 | PSP | DIAPH2 | ELRSGISDEKLLNCLESLRVsLTSNPVSWVNNFGHEGLGLL |
| Q17R91 | S820 | PSP | DIAPH2 | RLSSILFKLTFEEHINNIKPsIIAVTLACEELKKSESFNRL |
| Q17R91 | T66 | PSP | DIAPH2 | IQIKTLADDVRDRITSFRKStVKKEKPLIQHPIDSQVAMSE |
| Q17R91 | T882 | PSP | DIAPH2 | GFKINFLCKIRDTKSADQKTtLLHFIADICEEKYRDILKFP |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3KR16 | S543 | PSP | PLEKHG6 | KRELLTLYRDQDREsPstRPstPsLEGSQSSAEGRTPEFST |
| Q3KR16 | S546 | PSP | PLEKHG6 | LLTLYRDQDREsPstRPstPsLEGSQSSAEGRTPEFSTIIP |
| Q3KR16 | S645 | PSP | PLEKHG6 | ELRDIPLRPHPPDPQAPQRRsAPELPEGILKGGSLPQEDPP |
| Q3KR16 | S697 | PSP | PLEKHG6 | RGNVVVETLHRARLRGQLPSsPTHADSAGESPWESSGEEEE |
| Q3KR16 | T540 | PSP | PLEKHG6 | VQQKRELLTLYRDQDREsPstRPstPsLEGSQSSAEGRTPE |
| Q3KR16 | T544 | SIGNOR|PSP | PLEKHG6 | RELLTLYRDQDREsPstRPstPsLEGSQSSAEGRTPEFSTI |
| Q3KR16 | T620 | PSP | PLEKHG6 | GSRSPLSRLRQRALRRDPRLtFSTLELRDIPLRPHPPDPQA |
| Q53HL2 | S154 | EPSD|PSP | CDCA8 PESCRG3 | RKNLQTARVKRCPPSKKRTQsIQGKGKGKRSsRANtVTPAV |
| Q53HL2 | S165 | EPSD|PSP | CDCA8 PESCRG3 | CPPSKKRTQsIQGKGKGKRSsRANtVTPAVGRLEVSMVKPT |
| Q53HL2 | S219 | EPSD|PSP | CDCA8 PESCRG3 | tPGLRtPAAGERIyNIsGNGsPLADsKEIFLtVPVGGGEsL |
| Q53HL2 | S275 | EPSD|PSP | CDCA8 PESCRG3 | DPEALGNIKKLSNRLAQICSsIRtHK_______________ |
| Q53HL2 | T278 | EPSD|PSP | CDCA8 PESCRG3 | ALGNIKKLSNRLAQICSsIRtHK__________________ |
| Q53SF7 | S876 | PSP | COBLL1 KIAA0977 | RASNAQAKPSSFFLQMQKRVsGHYVTSAAAKSVHAAPNPAP |
| Q5JQF8 | S87 | Sugiyama | PABPC1L2A PABPC1L2 RBM32A; PABPC1L2B PABPC1L2 RBM32B | VIKGRPVRIMWSQRDPsLRKsGVGNVFIKNLGKTIDNKALY |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5QNW6 | S79 | EPSD | H2BC18 HIST2H2BF | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y84 | EPSD | H2BC18 HIST2H2BF | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5T1R4 | S1680 | Sugiyama | HIVEP3 KBP1 KIAA1555 KRC ZAS3 | ETYTMATAPHPEAGRLVPsSsRKPRMTEVHLPSLVSPEGQK |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q5T5U3 | S131 | PSP | ARHGAP21 ARHGAP10 KIAA1424 | GPAFEAGLCTGDRIIKVNGEsVIGKTYSQVIALIQNSDTTL |
| Q5UIP0 | S2205 | EPSD|PSP | RIF1 | GLKRsQEDEIssPVNKVRRVsFADPIYQAGLADDIDRRCSI |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q69YH5 | S542 | SIGNOR | CDCA2 | CNLLNTEVQPCKEKKINRRKsQETKCTKRALPKKSQVLKSC |
| Q69YH5 | S893 | EPSD|PSP | CDCA2 | LSDAIEQTFQRRNSETKVRRsTRLQKDLENEGLVWISLPLP |
| Q69YH5 | S977 | SIGNOR|PSP | CDCA2 | PENsQGPAAGSSDEPGKRRKsFCIsTLANTKATSQFKGYRR |
| Q69YH5 | S981 | SIGNOR|PSP | CDCA2 | QGPAAGSSDEPGKRRKsFCIsTLANTKATSQFKGYRRRSsL |
| Q6DN03 | S79 | EPSD | H2BC20P HIST2H2BC | AMGIMNSFLNDIFERIAGEAsRLAHyNKRSTITSRRSRRPC |
| Q6DN03 | Y84 | EPSD | H2BC20P HIST2H2BC | NSFLNDIFERIAGEAsRLAHyNKRSTITSRRSRRPCACCCP |
| Q6DRA6 | S79 | EPSD | H2BC19P HIST2H2BD | AMGIMNSFLNDIFERIAGEAsRLAHyNKRSTITSRRSRRPC |
| Q6DRA6 | Y84 | EPSD | H2BC19P HIST2H2BD | NSFLNDIFERIAGEAsRLAHyNKRSTITSRRSRRPCACCCP |
| Q6L8Q7 | S98 | Sugiyama | PDE12 | IATNALKGHAKAAAAKKSRKsRPNAsGGAACSGPGPEPAVF |
| Q6NZI2 | S300 | EPSD|PSP | CAVIN1 PTRF FKSG13 | RLVPAERREKLKTSRDKLRKsFtPDHVVyARSKTAVyKVPP |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71DI3 | S11 | EPSD | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | __________MARtKQTARKsTGGKAPRKQLATKAARKsAP |
| Q71DI3 | S29 | EPSD | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | RKsTGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q7KZF4 | S150 | Sugiyama | SND1 TDRD11 | EGLAtRREGMRANNPEQNRLsECEEQAKAAKKGMWSEGNGS |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z5L9 | S457 | Sugiyama | IRF2BP2 | GSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVGGQ |
| Q86V81 | S142 | Sugiyama | ALYREF ALY BEF THOC4 | IQELFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKA |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IVT2 | S348 | EPSD|PSP | MISP C19orf21 | RPLLTKLSLItAPRRERGRPsLYVQRDIVQETQREEDHRRE |
| Q8IX03 | S539 | SIGNOR|EPSD|PSP | WWC1 KIAA0869 KIBRA | QALRsLSGtPKSMTSLsPRSsLSsPSPPCsPLMADPLLAGD |
| Q8IX90 | S159 | SIGNOR | SKA3 C13orf3 RAMA1 | sDPPVASSCISEKsPRsPQLsDFGLERYIVSQVLPNPPQAV |
| Q8IZ21 | S117 | Sugiyama | PHACTR4 PRO2963 | KPSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIP |
| Q8N142 | S449 | Sugiyama | ADSS1 ADSSL1 | YIRFVENHVGVAVKWVGVGKsREsMIQLF____________ |
| Q8N142 | S452 | Sugiyama | ADSS1 ADSSL1 | FVENHVGVAVKWVGVGKsREsMIQLF_______________ |
| Q8NBJ5 | S607 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | DRAKSQKMREQQALSREAKNsDVLQsPLDsAARDEL_____ |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NEM2 | S634 | SIGNOR|EPSD|PSP | SHCBP1 | IVNELIAAStQKGQIKKKRLsELGITQADDNLMSQEMFVGI |
| Q8NEY8 | S110 | EPSD|PSP | PPHLN1 HSPC206 HSPC232 | DHsASRQPEYRDMRDGFRRKsFYsSHYARERSPYKRDNtFF |
| Q8NG31 | S24 | SIGNOR|EPSD|PSP | KNL1 CASC5 KIAA1570 | VSSEANEENDNIERPVRRRHsSILKPPRsPLQDLRGGNERV |
| Q8NG31 | S60 | SIGNOR|EPSD|PSP | KNL1 CASC5 KIAA1570 | GNERVQESNALRNKKNSRRVsFADTIKVFQTESHMKIVRKS |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TCS8 | S767 | Sugiyama | PNPT1 PNPASE | LSRKVLQsPAtTVVRTLNDRssIVMGEPIsQSSSNsQ____ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TE77 | S37 | EPSD|PSP | SSH3 SSH3L | tPVGPWDQAVQRRSRLQRRQsFAVLRGAVLGLQDGGDNDDA |
| Q8TEW0 | S962 | EPSD|PSP|Sugiyama | PARD3 PAR3 PAR3A | DEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQMNGNQ |
| Q8TEW0 | Y719 | Sugiyama | PARD3 PAR3 PAR3A | PELPIETALDDRERRIsHsLysGIEGLDEsPsRNAALsRIM |
| Q8TF76 | S108 | SIGNOR|PSP | HASPIN GSG2 | PKDRPsLTVtPKRWKLRARPsLtVtPRRLGLRARPPQKCSt |
| Q8TF76 | S143 | SIGNOR|EPSD|PSP | HASPIN GSG2 | PQKCStPCGPLRLPPFPsRDsGRLsPDLsVCGQPRDGDELG |
| Q8TF76 | S4 | PSP | HASPIN GSG2 | _________________MAAsLPGPGsRLFRtyGAADGRRQ |
| Q8TF76 | S93 | SIGNOR|EPSD|PSP | HASPIN GSG2 | GSPVRRRRRRPGGRVPKDRPsLTVtPKRWKLRARPsLtVtP |
| Q8WWI1 | S300 | EPSD|PSP | LMO7 FBX20 FBXO20 KIAA0858 | sEFTFKMQDYNKDDMsYRRIsAVEPKTALPFNRFLPNKSRQ |
| Q8WWI1 | S751 | EPSD|PSP | LMO7 FBX20 FBXO20 KIAA0858 | LKEQDQKWQDDLAKWKDRRKsYtSDLQKKKEEREEIEKQAL |
| Q8WWK9 | S628 | SIGNOR|EPSD|PSP | CKAP2 LB1 TMAP | QFDGTNsAFKELKFLtPVRRsRRLQEKTSKLPDMLKDHyPC |
| Q8WWK9 | T39 | EPSD|PSP | CKAP2 LB1 TMAP | QSAFKEQRRQKLKEHLLRRKtLFAYKQENEMLSSSRDQRVV |
| Q8WWM7 | S500 | Sugiyama | ATXN2L A2D A2LG A2LP A2RP | VTSSVSDPGVGsIsPAsPKIsLAPTDVKELSTKEPGRTLEP |
| Q8WYJ6 | S253 | PSP | SEPTIN1 DIFF6 PNUTL3 SEPT1 | VGSCEVVRDGGNRPVRGRRYsWGTVEVENPHHCDFLNLRRM |
| Q8WYJ6 | S312 | PSP | SEPTIN1 DIFF6 PNUTL3 SEPT1 | EGYRARCLQSLARPGARDRAsRSKLSRQsATEIPLPMLPLA |
| Q8WYJ6 | S320 | PSP | SEPTIN1 DIFF6 PNUTL3 SEPT1 | QSLARPGARDRAsRSKLSRQsATEIPLPMLPLADTEKLIRE |
| Q92538 | S174 | EPSD|PSP | GBF1 KIAA0248 | NESVCEIMQSCFRICFEMRLsELLRKSAEHTLVDMVQLLFT |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q92945 | S333 | Sugiyama | KHSRP FUBP2 | DRNEyGsRIGGGIDVPVPRHsVGVVIGRSGEMIKKIQNDAG |
| Q92974 | S960 | SIGNOR | ARHGEF2 KIAA0651 LFP40 | ssDPDtGsEEEGssRLsPPHsPRDFtRMQDIPEEtEsRDGE |
| Q92995 | S114 | PSP | USP13 ISOT3 | RHVREKVRGAsGGALPKRRNsKIFLDLDtDDDLNsDDYEYE |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q93079 | S79 | EPSD | H2BC9 H2BFJ HIST1H2BH | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y84 | EPSD | H2BC9 H2BFJ HIST1H2BH | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| Q96CF2 | S210 | SIGNOR|EPSD|PSP | CHMP4C SHAX3 | SSsLPAQPNRKPGMSSTARRsRAAssQRAEEEDDDIKQLAA |
| Q96CF2 | S214 | SIGNOR|EPSD|PSP | CHMP4C SHAX3 | PAQPNRKPGMSSTARRsRAAssQRAEEEDDDIKQLAAWAT_ |
| Q96CF2 | S215 | SIGNOR|EPSD|PSP | CHMP4C SHAX3 | AQPNRKPGMSSTARRsRAAssQRAEEEDDDIKQLAAWAT__ |
| Q96CV9 | S526 | Sugiyama | OPTN FIP2 GLC1E HIP7 HYPL NRP | FEDGGRQsLMEMQsRHGARtsDsDQQAyLVQRGAEDRDWRQ |
| Q96D15 | S117 | Sugiyama | RCN3 UNQ239/PRO272 | VsLAELRAWIAHTQQRHIRDsVsAAWDtyDtDRDGRVGWEE |
| Q96D46 | S462 | Sugiyama | NMD3 CGI-07 | FLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAE |
| Q96E39 | S326 | EPSD|PSP | RBMXL1 | GssRYDDysssRDGyGGsRDsYsssRsDLySsCDRVGRQER |
| Q96FF9 | S126 | SIGNOR|EPSD|PSP | CDCA5 | HsVPAtPtstPVPNPEAEsssKEGELDARDLEMsKKVRRsY |
| Q96FF9 | S139 | SIGNOR|EPSD|PSP | CDCA5 | NPEAEsssKEGELDARDLEMsKKVRRsYsRLEtLGsAstst |
| Q96FF9 | S164 | SIGNOR|EPSD|PSP | CDCA5 | RsYsRLEtLGsAststPGRRsCFGFEGLLGAEDLSGVsPVV |
| Q96FF9 | S33 | SIGNOR|EPSD|PSP | CDCA5 | QRSGPRAPsPtKPLRRsQRKsGsELPSILPEIWPKtPSAAA |
| Q96FF9 | S79 | EPSD|PSP | CDCA5 | VLKRIVAHAVEVPAVQsPRRsPRIsFFLEKENEPPGRELTK |
| Q96FF9 | S83 | SIGNOR|EPSD|PSP | CDCA5 | IVAHAVEVPAVQsPRRsPRIsFFLEKENEPPGRELTKEDLF |
| Q96FF9 | T111 | EPSD|PSP | CDCA5 | EPPGRELTKEDLFKtHsVPAtPtstPVPNPEAEsssKEGEL |
| Q96FF9 | T115 | EPSD|PSP | CDCA5 | RELTKEDLFKtHsVPAtPtstPVPNPEAEsssKEGELDARD |
| Q96FF9 | T151 | SIGNOR|EPSD|PSP | CDCA5 | LDARDLEMsKKVRRsYsRLEtLGsAststPGRRsCFGFEGL |
| Q96FF9 | T159 | EPSD|PSP | CDCA5 | sKKVRRsYsRLEtLGsAststPGRRsCFGFEGLLGAEDLSG |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96GD4 | S19 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | __MAQKENsyPWPYGRQtAPsGLsTLPQRVLRKEPVtPsAL |
| Q96GD4 | S22 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | AQKENsyPWPYGRQtAPsGLsTLPQRVLRKEPVtPsALVLM |
| Q96GD4 | S37 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | APsGLsTLPQRVLRKEPVtPsALVLMsRsNVQPTAAPGQKV |
| Q96GD4 | S43 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | TLPQRVLRKEPVtPsALVLMsRsNVQPTAAPGQKVMENssG |
| Q96GD4 | S45 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | PQRVLRKEPVtPsALVLMsRsNVQPTAAPGQKVMENssGtP |
| Q96GD4 | S61 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | LMsRsNVQPTAAPGQKVMENssGtPDILTRHFtIDDFEIGR |
| Q96GD4 | S62 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | MsRsNVQPTAAPGQKVMENssGtPDILTRHFtIDDFEIGRP |
| Q96GD4 | S7 | EPSD|PSP|Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | ______________MAQKENsyPWPYGRQtAPsGLsTLPQR |
| Q96GD4 | T16 | EPSD|PSP|Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | _____MAQKENsyPWPYGRQtAPsGLsTLPQRVLRKEPVtP |
| Q96GD4 | T232 | SIGNOR|ELM|EPSD|PSP|Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | GELKIADFGWSVHAPsLRRKtMCGtLDYLPPEMIEGRMHNE |
| Q96GD4 | T236 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | IADFGWSVHAPsLRRKtMCGtLDYLPPEMIEGRMHNEKVDL |
| Q96GD4 | T35 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | QtAPsGLsTLPQRVLRKEPVtPsALVLMsRsNVQPTAAPGQ |
| Q96GD4 | T64 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | RsNVQPTAAPGQKVMENssGtPDILTRHFtIDDFEIGRPLG |
| Q96GD4 | Y8 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | _____________MAQKENsyPWPYGRQtAPsGLsTLPQRV |
| Q96GD4 | Y92 | Sugiyama | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | FtIDDFEIGRPLGKGKFGNVyLAREKKSHFIVALKVLFKSQ |
| Q96K21 | S22 | PSP | ZFYVE19 ANCHR MPFYVE | NYDSQQPPLPPLPYAGCRRAsGFPALGRGGTVPVGVWGGAG |
| Q96PK6 | S618 | EPSD|PSP | RBM14 SIP | MSKRYGSDRRLAELsDYRRLsEsQLsFRRsPtKSSLDYRRL |
| Q96PK6 | S649 | EPSD|PSP | RBM14 SIP | tKSSLDYRRLPDAHsDyARYsGsYNDyLRAAQMHSGYQRRM |
| Q96RU3 | S497 | Sugiyama | FNBP1 FBP17 KIAA0554 | AWLAEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREs |
| Q99661 | S109 | EPSD|PSP | KIF2C KNSL6 | QKQKRRsVNSKIPAPKEsLRsRsTRMstVSELRITAQENDM |
| Q99661 | S111 | SIGNOR|EPSD|PSP | KIF2C KNSL6 | QKRRsVNSKIPAPKEsLRsRsTRMstVSELRITAQENDMEV |
| Q99661 | S115 | EPSD|PSP | KIF2C KNSL6 | sVNSKIPAPKEsLRsRsTRMstVSELRITAQENDMEVELPA |
| Q99661 | S192 | SIGNOR|EPSD|PSP | KIF2C KNSL6 | QVHsIRGsssANPVNsVRRKsCLVKEVEKMKNKREEKKAQN |
| Q99661 | S95 | SIGNOR|ELM|EPSD|PSP | KIF2C KNSL6 | HPKDNLPLQENVtIQKQKRRsVNSKIPAPKEsLRsRsTRMs |
| Q99755 | S475 | Sugiyama | PIP5K1A | LKPsPsKKFRSGssFSRRAGssGNsCItyQPsVsGEHKAQV |
| Q99848 | S264 | Sugiyama | EBNA1BP2 EBP2 | KNQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRP |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99877 | S79 | EPSD | H2BC15 H2BFD HIST1H2BN | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y84 | EPSD | H2BC15 H2BFD HIST1H2BN | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S79 | EPSD | H2BC14 H2BFE HIST1H2BM | AMGIMNsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAV |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y84 | EPSD | H2BC14 H2BFE HIST1H2BM | NsFVNDIFERIAGEAsRLAHyNKRStItsREIQTAVRLLLP |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q9BQG0 | S1303 | SIGNOR|EPSD|PSP | MYBBP1A P160 | KKGVLGKsPLsALARKKARLsLVIRSPsLLQSGAKKKAQVR |
| Q9BRK5 | S99 | Sugiyama | SDF4 CAB45 PSEC0034 | QEVFLGKDLGGFDEDAEPRRsRRKLMVIFSKVDVNTDRKIS |
| Q9BW61 | S33 | EPSD|PSP | DDA1 C19orf58 PCIA1 | KSNFSRFHADSVCKASNRRPsVYLPTREYPSEQIIVTEKTN |
| Q9BXS6 | S240 | EPSD|PSP | NUSAP1 ANKT BM-037 PRO0310 | KQQPINKGGVRTPVPPRGRLsVAstPIsQRRsQGRsCGPAs |
| Q9C0C2 | S936 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | GRyssQDADEQDWEFQKRDVsLGTyGSRAAEPQEQEFGKSA |
| Q9GZT3 | S15 | Sugiyama | SLIRP C14orf156 DC23 DC50 PD04872 | ______MAASAARGAAALRRsINQPVAFVRRIPWTAASSQL |
| Q9H008 | S241 | Sugiyama | LHPP | GGAQRCGMRALQVRTGKFRPsDEHHPEVKADGYVDNLAEAV |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H0H5 | S144 | SIGNOR|iPTMNet | RACGAP1 KIAA1478 MGCRACGAP | ALAFLNRGQPSSSNAGNKRLstIDEsGsILsDIsFDKtDEs |
| Q9H0H5 | S185 | SIGNOR|iPTMNet | RACGAP1 KIAA1478 MGCRACGAP | LDWDssLVKTFKLKKREKRRstsRQFVDGPPGPVKKtRsIG |
| Q9H0H5 | S187 | SIGNOR|iPTMNet | RACGAP1 KIAA1478 MGCRACGAP | WDssLVKTFKLKKREKRRstsRQFVDGPPGPVKKtRsIGsA |
| Q9H0H5 | S387 | SIGNOR|ELM|iPTMNet|EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | VHCVNEIEQRGLTETGLyRIsGCDRTVKELKEKFLRVKTVP |
| Q9H0H5 | S410 | ELM|iPTMNet|EPSD | RACGAP1 KIAA1478 MGCRACGAP | DRTVKELKEKFLRVKTVPLLsKVDDIHAICSLLKDFLRNLK |
| Q9H0H5 | T145 | SIGNOR|iPTMNet | RACGAP1 KIAA1478 MGCRACGAP | LAFLNRGQPSSSNAGNKRLstIDEsGsILsDIsFDKtDEsL |
| Q9H0H5 | T186 | SIGNOR|iPTMNet | RACGAP1 KIAA1478 MGCRACGAP | DWDssLVKTFKLKKREKRRstsRQFVDGPPGPVKKtRsIGs |
| Q9H0H5 | T249 | EPSD|PSP | RACGAP1 KIAA1478 MGCRACGAP | PIEAVSTIETVPYWtRSRRKtGtLQPWNsDstLNSRQLEPR |
| Q9H211 | S143 | PSP | CDT1 | LASCLQRARELGARVRALKAsAQDAGEsCtPEAEGRPEEPC |
| Q9H211 | T102 | PSP | CDT1 | tPEAPDIPACPsPGQKIKKStPAAGQPPHLTSAQDQDTISE |
| Q9H211 | T358 | PSP | CDT1 | DEVPDIEPAALPQPPATEKLtTAQEVLARARNLIsPRMEKA |
| Q9H211 | T7 | PSP | CDT1 | ______________MEQRRVtDFFARRRPGPPRIAPPKLAC |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H3Q1 | S309 | Sugiyama | CDC42EP4 BORG4 CEP4 | AAPsPGsARSMGSHTTRDSSsLssCtsGILEERsPAFRGPD |
| Q9H410 | S100 | SIGNOR|EPSD|PSP | DSN1 C20orf172 MIS13 | LsPQEQsAsYQDRRQSWRRAsMKETNRRKsLHPIHQGITEL |
| Q9H410 | S109 | SIGNOR|EPSD|PSP | DSN1 C20orf172 MIS13 | YQDRRQSWRRAsMKETNRRKsLHPIHQGITELSRsIsVDLA |
| Q9H6F5 | S255 | EPSD|PSP | CCDC86 CYCLON | IPKGKPKSGRVWKDRSKKRFsQMLQDKPLRTSWQRKMKERQ |
| Q9H788 | S261 | EPSD|PSP | SH2D4A PPP1R38 SH2A | AADEKRRSLAKQAREDYKRLsLGAQKGRGGERLQsPLRVPQ |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H7D7 | S123 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | SSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLNQT |
| Q9H814 | T151 | Sugiyama | PHAX RNUXA | ATELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDL |
| Q9HA77 | S544 | Sugiyama | CARS2 OK/SW-cl.10 | EACDTLRRGLTAHGINIKDRssttstWELLDQRTKDQKSAG |
| Q9NP77 | S19 | SIGNOR|EPSD|PSP | SSU72 HSPC182 PNAS-120 | __MPssPLRVAVVCSSNQNRsMEAHNILSKRGFSVRSFGTG |
| Q9NP77 | S3 | PSP | SSU72 HSPC182 PNAS-120 | __________________MPssPLRVAVVCSSNQNRsMEAH |
| Q9NP77 | S4 | PSP | SSU72 HSPC182 PNAS-120 | _________________MPssPLRVAVVCSSNQNRsMEAHN |
| Q9NQG5 | S145 | SIGNOR|PSP | RPRD1B C20orf77 CREPT | LKLSMEDsKsPPPKATEEKKsLKRTFQQIQEEEDDDyPGsy |
| Q9NQS7 | S518 | EPSD|PSP | INCENP | tVQRNQMLMtPtsAPRSVMKsFIKRNTPLRMDPKCSFVEKE |
| Q9NQS7 | S72 | EPSD|PSP | INCENP | EPELMPKtPSQKNRRKKRRIsYVQDENRDPIRRRLSRRKsR |
| Q9NQS7 | S828 | Sugiyama | INCENP | PQGHRAPPKINPDNYGMDLNsDDstDDEAHPRKPIPTWARG |
| Q9NQS7 | S831 | Sugiyama | INCENP | HRAPPKINPDNYGMDLNsDDstDDEAHPRKPIPTWARGTPL |
| Q9NQS7 | S893 | SIGNOR|EPSD|PSP | INCENP | LPLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLAY |
| Q9NQS7 | S894 | SIGNOR|EPSD|PSP|Sugiyama | INCENP | PLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLAYs |
| Q9NQS7 | S899 | ELM|EPSD|PSP|Sugiyama | INCENP | DIFKKSKPRYHKRtssAVWNsPPLQGARVPssLAYsLKKH_ |
| Q9NQS7 | S909 | Sugiyama | INCENP | HKRtssAVWNsPPLQGARVPssLAYsLKKH___________ |
| Q9NQS7 | S910 | Sugiyama | INCENP | KRtssAVWNsPPLQGARVPssLAYsLKKH____________ |
| Q9NQS7 | S914 | Sugiyama | INCENP | sAVWNsPPLQGARVPssLAYsLKKH________________ |
| Q9NQS7 | T494 | EPSD|PSP | INCENP | PRsKtPSsPCPASKVVRPLRtFLHtVQRNQMLMtPtsAPRS |
| Q9NQS7 | T59 | EPSD|PSP | INCENP | EEAERMFTREFSKEPELMPKtPSQKNRRKKRRIsYVQDENR |
| Q9NQS7 | T832 | Sugiyama | INCENP | RAPPKINPDNYGMDLNsDDstDDEAHPRKPIPTWARGTPLS |
| Q9NQS7 | T892 | SIGNOR|EPSD|PSP|Sugiyama | INCENP | ILPLDLEDIFKKSKPRYHKRtssAVWNsPPLQGARVPssLA |
| Q9NQZ2 | S462 | EPSD|PSP | UTP3 CRLZ1 SAS10 | RAKIRRRGQVREVRKEEQRYsGELsGIRAGVKKSIKLK___ |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NRF8 | S568 | Sugiyama | CTPS2 | TGNLNAYLQQGCKLsssDRysDAsDDsFSEPRIAELEIS__ |
| Q9NRL2 | S1363 | Sugiyama | BAZ1A ACF1 WCRF180 HSPC317 | LQADVFVELLsPRRKRRGRKsANNtPENsPNFPNFRVIATK |
| Q9NS23 | S207 | SIGNOR | RASSF1 RDA32 | PsLQDARRGPGRGTSVRRRtsFYLPKDAVKHLHVLSRTRAR |
| Q9NYF8 | S319 | Sugiyama | BCLAF1 BTF KIAA0164 | RsPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKR |
| Q9NYF8 | S320 | Sugiyama | BCLAF1 BTF KIAA0164 | sPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKRF |
| Q9NYP9 | S36 | EPSD|PSP | MIS18A C21orf45 C21orf46 FASP1 | GCECGDKGKCsDssLLGKRLsEDssRHQLLQKWASMWSSMS |
| Q9NZL9 | S9 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | ____________MVGREKELsIHFVPGsCRLVEEEVNIPNR |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9P227 | S127 | EPSD|PSP | ARHGAP23 KIAA1501 | GPAHRAGLRTGDRLVKVNGEsVIGKTYSQVIALIQNSDDTL |
| Q9P287 | S12 | Sugiyama | BCCIP TOK1 | _________MASRSKRRAVEsGVPQPPDPPVQRDEEEEKEV |
| Q9UBB4 | S12 | EPSD|PSP | ATXN10 SCA10 | _________MAAPRPPPARLsGVMVPAPIQDLEALRALTAL |
| Q9UGV2 | S334 | Sugiyama | NDRG3 | GYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDG |
| Q9UGV2 | S335 | Sugiyama | NDRG3 | YIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGt |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UJ70 | S76 | EPSD|PSP | NAGK | AKRKAGVDPLVPLRsLGLsLsGGDQEDAGRILIEELRDRFP |
| Q9UKV0 | S239 | SIGNOR | HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR | AsEPNLKVRSRLKQKVAERRssPLLRRKDGNVVTsFKKRMF |
| Q9UKV3 | S240 | Sugiyama | ACIN1 ACINUS KIAA0670 | KPRKGERRSSRVRQARAAKLsEGsQPAEEEEDQEtPsRNLR |
| Q9UKX7 | S52 | Sugiyama | NUP50 NPAP60L PRO1146 | EEVLKNRAIKKAKRRNVGFEsDtGGAFKGFKGLVVPSGGGR |
| Q9ULD2 | S1224 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | tEQAVLQESLEKESKVNKRLsMENEELLWKLHNGDLCsPKR |
| Q9ULD2 | S1259 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | LCsPKRsPtssAIPLQsPRNsGsFPsPsIsPR_________ |
| Q9UNZ2 | S74 | Sugiyama | NSFL1C UBXN2C | SQATPssVsRGTAPSDNRVtsFRDLIHDQDEDEEEEEGQRF |
| Q9UPQ0 | S177 | Sugiyama | LIMCH1 KIAA1102 | LAQMRKDTDDIEsPKRSIRDsGyIDCWDsERsDsLsPPRHG |
| Q9UPY8 | S176 | SIGNOR|EPSD|PSP | MAPRE3 | AVPQRtsPtGPKNMQTSGRLsNVAPPCILRKNPPSARNGGH |
| Q9UQ35 | S1099 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHsEsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRG |
| Q9UQ35 | S1101 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEF |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQB9 | T198 | Sugiyama | AURKC AIE2 AIK3 AIRK3 ARK3 STK13 | GEVKIADFGWSVHTPSLRRKtMCGtLDYLPPEMIEGRTYDE |
| Q9UQB9 | T202 | Sugiyama | AURKC AIE2 AIK3 AIRK3 ARK3 STK13 | IADFGWSVHTPSLRRKtMCGtLDYLPPEMIEGRTYDEKVDL |
| Q9UQB9 | Y58 | Sugiyama | AURKC AIE2 AIK3 AIRK3 ARK3 STK13 | LTVDDFEIGRPLGKGKFGNVyLARLKESHFIVALKVLFKSQ |
| Q9UQL6 | S278 | SIGNOR|EPSD|PSP | HDAC5 KIAA0600 | AsEPNLKVRSRLKQKVAERRssPLLRRKDGTVIStFKKRAV |
| Q9Y230 | S43 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | GAHSHIRGLGLDDALEPRQAsQGMVGQLAARRAAGVVLEMI |
| Q9Y266 | T40 | EPSD|PSP | NUDC | QHEGGVQELVNTFFSFLRRKtDFFIGGEEGMAEKLItQTFs |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2I6 | S185 | SIGNOR|EPSD|PSP | NINL KIAA0980 NLP | QNELFEAQGQLQTWDSEDFGsPQKSCsPSFDTPESQIRGVW |
| Q9Y2I6 | S448 | SIGNOR|EPSD|PSP | NINL KIAA0980 NLP | LEQLTEKKIKHLEQGYRERLsLLRSEVEAERELFWEQAHRQ |
| Q9Y2I6 | S585 | SIGNOR|EPSD|PSP | NINL KIAA0980 NLP | NDELQAELEGLWARLPKNRHsPSWsPDGRRRQLPGLGPAGI |
| Q9Y2R4 | S22 | EPSD|PSP | DDX52 ROK1 HUSSY-19 | DVHDLFRRLGAGAKFDTRRFsADAARFQIGKRKYDFDSSEV |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y520 | S1013 | EPSD|PSP | PRRC2C BAT2D1 BAT2L2 KIAA1096 XTP2 | WGPRPSSNRREEVNDRPVRRsGPIKKPVLRDMKEEREQRKE |
| Q9Y5B9 | T494 | EPSD|PSP | SUPT16H FACT140 FACTP140 | RRAHQKELAAQLNEEAKRRLtEQKGEQQIQKARKSNVSYKN |
| Q9Y6D5 | S277 | Sugiyama | ARFGEF2 ARFGEP2 BIG2 | RSDSGKVSTENGDAPRERGssLsGtDDGAQEVVKDILEDVV |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| NRAGE signals death through JNK | R-HSA-193648 | 7.410771e-07 | 6.130 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.710400e-06 | 5.767 | 1 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.350884e-06 | 5.629 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.702473e-06 | 5.568 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.114535e-06 | 5.291 | 1 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.904568e-06 | 5.229 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.730744e-05 | 4.762 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.588844e-05 | 4.799 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.641026e-05 | 4.785 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.027636e-05 | 4.519 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.640471e-05 | 4.439 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 5.194326e-05 | 4.284 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.883851e-05 | 4.162 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.516096e-05 | 4.022 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.291971e-04 | 3.889 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.347368e-04 | 3.871 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.387290e-04 | 3.858 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.329562e-04 | 3.633 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.592614e-04 | 3.586 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.352650e-04 | 3.475 | 1 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.134073e-04 | 3.384 | 1 | 1 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.134073e-04 | 3.384 | 1 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.535830e-04 | 3.452 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.157221e-04 | 3.381 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.994585e-04 | 3.399 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.798289e-04 | 3.237 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.185945e-04 | 3.209 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.413092e-04 | 3.193 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 9.583104e-04 | 3.018 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.002661e-03 | 2.999 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.019410e-03 | 2.992 | 1 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.071788e-03 | 2.970 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.349357e-03 | 2.870 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.459344e-03 | 2.836 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.560210e-03 | 2.807 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.001201e-03 | 2.699 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.222787e-03 | 2.653 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.408057e-03 | 2.618 | 1 | 1 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.897635e-03 | 2.538 | 1 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.618154e-03 | 2.442 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.881354e-03 | 2.411 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.389250e-03 | 2.358 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.408346e-03 | 2.356 | 1 | 1 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.371669e-03 | 2.359 | 1 | 1 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.872842e-03 | 2.312 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.222499e-03 | 2.206 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.253356e-03 | 2.204 | 1 | 1 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.717703e-03 | 2.173 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.066297e-03 | 2.151 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.066297e-03 | 2.151 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 8.462947e-03 | 2.072 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 8.462947e-03 | 2.072 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 8.462947e-03 | 2.072 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 8.462947e-03 | 2.072 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 8.753727e-03 | 2.058 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.993209e-03 | 2.046 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.002176e-02 | 1.999 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.752552e-03 | 2.011 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.073386e-02 | 1.969 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.071226e-02 | 1.970 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.063670e-02 | 1.973 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.220356e-02 | 1.914 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.266335e-02 | 1.897 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.347089e-02 | 1.871 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.347089e-02 | 1.871 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.347089e-02 | 1.871 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.278222e-02 | 1.893 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.347089e-02 | 1.871 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.355895e-02 | 1.868 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.503920e-02 | 1.823 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.487535e-02 | 1.828 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.452920e-02 | 1.838 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.563299e-02 | 1.806 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.656935e-02 | 1.781 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.636080e-02 | 1.786 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.633490e-02 | 1.787 | 1 | 0 |
| Muscle contraction | R-HSA-397014 | 1.655597e-02 | 1.781 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.782353e-02 | 1.749 | 1 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.772979e-02 | 1.751 | 1 | 1 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.752549e-02 | 1.756 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.771210e-02 | 1.752 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.999039e-02 | 1.699 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.185794e-02 | 1.660 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.134685e-02 | 1.671 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.208611e-02 | 1.656 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.209870e-02 | 1.656 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.301023e-02 | 1.638 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.348273e-02 | 1.629 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.610417e-02 | 1.583 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.586059e-02 | 1.587 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.873044e-02 | 1.542 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.873044e-02 | 1.542 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.873044e-02 | 1.542 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.873044e-02 | 1.542 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.873044e-02 | 1.542 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.747868e-02 | 1.561 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.770978e-02 | 1.557 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.774459e-02 | 1.557 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.055152e-02 | 1.515 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.055152e-02 | 1.515 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.109664e-02 | 1.507 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.139605e-02 | 1.503 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.276537e-02 | 1.485 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.366063e-02 | 1.473 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.321110e-02 | 1.479 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.201241e-02 | 1.495 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.366063e-02 | 1.473 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.433270e-02 | 1.464 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.606503e-02 | 1.443 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.781290e-02 | 1.422 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.762834e-02 | 1.424 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.750483e-02 | 1.426 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.524798e-02 | 1.453 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.781290e-02 | 1.422 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.778691e-02 | 1.423 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.752615e-02 | 1.426 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.785080e-02 | 1.422 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.848675e-02 | 1.415 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.076595e-02 | 1.390 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.096446e-02 | 1.388 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.107404e-02 | 1.386 | 1 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.511137e-02 | 1.346 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.164498e-02 | 1.380 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.511137e-02 | 1.346 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.377001e-02 | 1.359 | 1 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.370286e-02 | 1.359 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.567402e-02 | 1.340 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.902381e-02 | 1.310 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.647681e-02 | 1.333 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.647681e-02 | 1.333 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.974035e-02 | 1.303 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.974035e-02 | 1.303 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.997298e-02 | 1.301 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.990174e-02 | 1.302 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.602251e-02 | 1.337 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.678532e-02 | 1.330 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.633882e-02 | 1.334 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.602251e-02 | 1.337 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.074261e-02 | 1.295 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.369221e-02 | 1.270 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.416005e-02 | 1.266 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 5.939868e-02 | 1.226 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 5.939868e-02 | 1.226 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.795234e-02 | 1.237 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.795234e-02 | 1.237 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.109824e-02 | 1.214 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.109824e-02 | 1.214 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.109824e-02 | 1.214 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.109824e-02 | 1.214 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.109824e-02 | 1.214 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 5.989517e-02 | 1.223 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.607203e-02 | 1.251 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.878782e-02 | 1.231 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.603821e-02 | 1.252 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.795234e-02 | 1.237 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.109824e-02 | 1.214 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.795234e-02 | 1.237 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.792794e-02 | 1.237 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.124178e-02 | 1.213 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.224865e-01 | 0.912 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.224865e-01 | 0.912 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.224865e-01 | 0.912 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.224865e-01 | 0.912 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.224865e-01 | 0.912 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.224865e-01 | 0.912 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.224865e-01 | 0.912 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.224865e-01 | 0.912 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.224865e-01 | 0.912 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.224865e-01 | 0.912 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.224865e-01 | 0.912 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.224865e-01 | 0.912 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.224865e-01 | 0.912 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.224865e-01 | 0.912 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.224865e-01 | 0.912 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.224865e-01 | 0.912 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.224865e-01 | 0.912 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.224865e-01 | 0.912 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 9.712615e-02 | 1.013 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 9.712615e-02 | 1.013 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.299763e-01 | 0.638 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.299763e-01 | 0.638 | 0 | 0 |
| Tandem pore domain halothane-inhibited K+ channel (THIK) | R-HSA-1299287 | 2.299763e-01 | 0.638 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.299763e-01 | 0.638 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.299763e-01 | 0.638 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.299763e-01 | 0.638 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.524484e-02 | 1.185 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.524484e-02 | 1.185 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.397250e-01 | 0.855 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.397250e-01 | 0.855 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 8.876859e-02 | 1.052 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.876859e-02 | 1.052 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 8.876859e-02 | 1.052 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.438102e-02 | 1.129 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.438102e-02 | 1.129 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.438102e-02 | 1.129 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.152863e-01 | 0.938 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.152863e-01 | 0.938 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.854372e-01 | 0.732 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.854372e-01 | 0.732 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.854372e-01 | 0.732 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.243048e-01 | 0.489 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.243048e-01 | 0.489 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.243048e-01 | 0.489 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.243048e-01 | 0.489 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.243048e-01 | 0.489 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.243048e-01 | 0.489 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.243048e-01 | 0.489 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.243048e-01 | 0.489 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.243048e-01 | 0.489 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.243048e-01 | 0.489 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.243048e-01 | 0.489 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.243048e-01 | 0.489 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.243048e-01 | 0.489 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.243048e-01 | 0.489 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.443577e-01 | 0.841 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.443577e-01 | 0.841 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.443577e-01 | 0.841 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.443577e-01 | 0.841 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.443577e-01 | 0.841 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.133659e-01 | 0.946 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.133659e-01 | 0.946 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.133659e-01 | 0.946 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.133659e-01 | 0.946 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.328617e-01 | 0.633 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.328617e-01 | 0.633 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.328617e-01 | 0.633 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.328617e-01 | 0.633 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.981699e-02 | 1.047 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.755266e-01 | 0.756 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.755266e-01 | 0.756 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.356255e-01 | 0.868 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.356255e-01 | 0.868 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.356255e-01 | 0.868 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.063803e-01 | 0.973 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.063803e-01 | 0.973 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.063803e-01 | 0.973 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.063803e-01 | 0.973 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.429424e-02 | 1.074 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 8.429424e-02 | 1.074 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.802088e-02 | 1.108 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.083407e-01 | 0.681 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.083407e-01 | 0.681 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.808940e-01 | 0.551 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.808940e-01 | 0.551 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.808940e-01 | 0.551 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.808940e-01 | 0.551 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.808940e-01 | 0.551 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.070828e-01 | 0.390 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.070828e-01 | 0.390 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.070828e-01 | 0.390 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.070828e-01 | 0.390 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.070828e-01 | 0.390 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.070828e-01 | 0.390 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.070828e-01 | 0.390 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.070828e-01 | 0.390 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.070828e-01 | 0.390 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.070828e-01 | 0.390 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.070828e-01 | 0.390 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.070828e-01 | 0.390 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.070828e-01 | 0.390 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.070828e-01 | 0.390 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.169096e-02 | 1.145 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.169096e-02 | 1.145 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.423660e-01 | 0.616 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.423660e-01 | 0.616 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.249958e-02 | 1.034 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.040737e-01 | 0.983 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.459159e-01 | 0.836 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.112026e-01 | 0.675 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.286740e-01 | 0.483 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.286740e-01 | 0.483 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.286740e-01 | 0.483 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.838669e-02 | 1.165 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.301771e-01 | 0.885 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.771968e-01 | 0.557 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.454048e-01 | 0.837 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.386285e-01 | 0.622 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.386285e-01 | 0.622 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.035712e-01 | 0.985 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.079376e-01 | 0.682 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.276660e-01 | 0.894 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.021535e-01 | 0.991 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.002896e-01 | 0.999 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.782186e-01 | 0.749 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.312180e-01 | 0.636 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.312180e-01 | 0.636 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.668159e-01 | 0.574 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.124616e-01 | 0.505 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.124616e-01 | 0.505 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.755431e-01 | 0.425 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.755431e-01 | 0.425 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.755431e-01 | 0.425 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.755431e-01 | 0.425 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.755431e-01 | 0.425 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.755431e-01 | 0.425 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.755431e-01 | 0.425 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.797240e-01 | 0.319 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.797240e-01 | 0.319 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.797240e-01 | 0.319 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.797240e-01 | 0.319 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.797240e-01 | 0.319 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.797240e-01 | 0.319 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.797240e-01 | 0.319 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.797240e-01 | 0.319 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.154533e-02 | 1.145 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.819110e-02 | 1.055 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.819110e-02 | 1.055 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.093737e-01 | 0.961 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.093737e-01 | 0.961 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.729684e-01 | 0.762 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.957038e-01 | 0.708 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.226547e-01 | 0.652 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.226547e-01 | 0.652 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.551948e-01 | 0.593 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.673613e-01 | 0.776 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.955576e-01 | 0.529 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 2.955576e-01 | 0.529 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.086342e-01 | 0.964 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.478265e-01 | 0.459 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.748479e-01 | 0.757 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.797371e-01 | 0.553 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.220199e-01 | 0.654 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.651737e-01 | 0.576 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.651737e-01 | 0.576 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.651737e-01 | 0.576 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.210079e-01 | 0.376 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.210079e-01 | 0.376 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.210079e-01 | 0.376 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.596059e-01 | 0.797 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.871629e-01 | 0.542 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.871629e-01 | 0.542 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.871629e-01 | 0.542 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.871629e-01 | 0.542 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.871629e-01 | 0.542 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.871629e-01 | 0.542 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.829968e-01 | 0.417 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.829968e-01 | 0.417 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.829968e-01 | 0.417 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.073758e-01 | 0.683 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.539237e-01 | 0.451 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.095183e-01 | 0.509 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.754686e-01 | 0.560 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.754686e-01 | 0.560 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.940303e-01 | 0.532 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.321504e-01 | 0.479 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.321504e-01 | 0.479 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.554777e-01 | 0.449 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.831881e-01 | 0.417 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.831881e-01 | 0.417 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.177167e-01 | 0.379 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.434693e-01 | 0.265 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.434693e-01 | 0.265 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.077089e-01 | 0.683 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.128780e-01 | 0.505 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.549718e-01 | 0.450 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.810229e-01 | 0.419 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.122900e-01 | 0.385 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.122900e-01 | 0.385 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.122900e-01 | 0.385 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.122900e-01 | 0.385 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.535207e-01 | 0.596 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.517682e-01 | 0.345 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.517682e-01 | 0.345 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.517682e-01 | 0.345 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.008461e-01 | 0.397 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.063965e-01 | 0.296 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.668140e-01 | 0.436 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.953553e-01 | 0.403 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.900821e-01 | 0.409 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.900821e-01 | 0.409 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.237402e-01 | 0.373 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.237402e-01 | 0.373 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.849689e-01 | 0.314 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.849689e-01 | 0.314 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.849689e-01 | 0.314 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.849689e-01 | 0.314 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.163605e-01 | 0.381 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.694471e-01 | 0.328 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.032839e-01 | 0.394 | 1 | 1 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.973855e-01 | 0.401 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.593098e-01 | 0.445 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.593098e-01 | 0.445 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.749083e-01 | 0.426 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.749083e-01 | 0.426 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.581307e-01 | 0.339 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.581307e-01 | 0.339 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.972611e-01 | 0.303 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.972611e-01 | 0.303 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.171697e-01 | 0.286 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.171697e-01 | 0.286 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.171697e-01 | 0.286 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.171697e-01 | 0.286 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 5.459078e-01 | 0.263 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.994077e-01 | 0.222 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.994077e-01 | 0.222 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.994077e-01 | 0.222 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.994077e-01 | 0.222 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.994077e-01 | 0.222 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.994077e-01 | 0.222 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.994077e-01 | 0.222 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.994077e-01 | 0.222 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.994077e-01 | 0.222 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.077117e-01 | 0.390 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.135994e-01 | 0.383 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.490884e-01 | 0.348 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.490373e-01 | 0.348 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.913871e-01 | 0.309 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.062245e-01 | 0.296 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.646135e-01 | 0.333 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.869394e-01 | 0.313 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.244300e-01 | 0.280 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.482519e-01 | 0.261 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.482519e-01 | 0.261 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.482519e-01 | 0.261 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.301547e-01 | 0.276 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.013805e-01 | 0.300 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 5.246477e-01 | 0.280 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.508707e-01 | 0.259 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.508707e-01 | 0.259 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.508707e-01 | 0.259 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.831503e-01 | 0.234 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.831503e-01 | 0.234 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.535521e-01 | 0.257 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.562065e-01 | 0.255 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.781244e-01 | 0.238 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.444836e-01 | 0.264 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.613183e-01 | 0.251 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.765139e-01 | 0.239 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.763632e-01 | 0.239 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.769503e-01 | 0.239 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.899038e-01 | 0.229 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.930538e-01 | 0.227 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.985426e-01 | 0.223 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.067207e-01 | 0.217 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.067207e-01 | 0.217 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.180870e-01 | 0.209 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.180870e-01 | 0.209 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.180870e-01 | 0.209 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.180870e-01 | 0.209 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.139403e-01 | 0.212 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.107120e-01 | 0.956 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.335692e-01 | 0.273 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.038602e-01 | 0.394 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.749083e-01 | 0.426 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.913871e-01 | 0.309 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.433057e-01 | 0.844 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.422666e-02 | 1.075 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.763632e-01 | 0.239 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.482519e-01 | 0.261 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.482519e-01 | 0.261 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.293601e-01 | 0.888 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.321504e-01 | 0.479 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.290421e-01 | 0.483 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.098504e-01 | 0.678 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.301547e-01 | 0.276 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.754686e-01 | 0.560 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.429424e-02 | 1.074 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.312180e-01 | 0.636 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.367543e-01 | 0.864 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.066241e-01 | 0.972 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.237402e-01 | 0.373 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.935867e-01 | 0.532 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.062245e-01 | 0.296 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.760326e-01 | 0.754 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.249958e-02 | 1.034 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.797371e-01 | 0.553 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.137787e-01 | 0.944 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.300030e-01 | 0.481 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.008461e-01 | 0.397 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.973855e-01 | 0.401 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.984557e-01 | 0.525 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.282561e-02 | 1.138 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.476791e-01 | 0.261 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.122900e-01 | 0.385 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.668140e-01 | 0.436 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.438102e-02 | 1.129 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.435593e-01 | 0.843 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.609451e-01 | 0.583 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.882419e-01 | 0.725 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.778975e-01 | 0.423 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.179388e-01 | 0.498 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.180870e-01 | 0.209 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.226547e-01 | 0.652 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.754686e-01 | 0.560 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.854838e-01 | 0.732 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.493609e-01 | 0.826 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.769503e-01 | 0.239 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.596059e-01 | 0.797 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.398502e-01 | 0.469 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.392726e-01 | 0.268 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.470571e-02 | 1.127 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.386285e-01 | 0.622 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.413799e-01 | 0.617 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.338313e-01 | 0.273 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.289642e-02 | 1.032 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.083407e-01 | 0.681 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.423660e-01 | 0.616 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.423660e-01 | 0.616 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.124616e-01 | 0.505 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.539237e-01 | 0.451 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.071754e-01 | 0.684 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.207174e-01 | 0.656 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.409488e-01 | 0.356 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.173105e-01 | 0.663 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.173105e-01 | 0.663 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.781244e-01 | 0.238 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.256779e-01 | 0.279 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.893563e-01 | 0.723 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.862295e-02 | 1.006 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.289642e-02 | 1.032 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.083407e-01 | 0.681 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.808940e-01 | 0.551 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.808940e-01 | 0.551 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.427710e-02 | 1.129 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.423660e-01 | 0.616 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.639838e-01 | 0.785 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.771968e-01 | 0.557 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.294980e-01 | 0.888 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.755431e-01 | 0.425 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.817494e-01 | 0.741 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.572453e-01 | 0.590 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.778975e-01 | 0.423 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 4.517682e-01 | 0.345 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.063965e-01 | 0.296 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.710049e-01 | 0.431 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.910464e-01 | 0.408 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.972611e-01 | 0.303 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.482519e-01 | 0.261 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.763632e-01 | 0.239 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.820524e-01 | 0.235 | 1 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.820524e-01 | 0.235 | 1 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.195546e-01 | 0.208 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.918234e-01 | 0.407 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.527749e-01 | 0.597 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.690765e-01 | 0.329 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.787880e-01 | 0.320 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.433057e-01 | 0.844 | 1 | 1 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.729684e-01 | 0.762 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.051176e-01 | 0.688 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.357553e-01 | 0.867 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.155401e-01 | 0.937 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.915321e-01 | 0.535 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.278539e-01 | 0.277 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.512280e-01 | 0.259 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.899038e-01 | 0.229 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.130364e-01 | 0.504 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.140624e-01 | 0.943 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.535337e-01 | 0.814 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.694471e-01 | 0.328 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 4.760455e-01 | 0.322 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.924325e-01 | 0.716 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.078435e-01 | 0.967 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.111469e-01 | 0.675 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.290421e-01 | 0.483 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.470571e-02 | 1.127 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.470571e-02 | 1.127 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.328617e-01 | 0.633 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.755266e-01 | 0.756 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.594880e-01 | 0.797 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.083407e-01 | 0.681 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.112026e-01 | 0.675 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.668159e-01 | 0.574 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.124616e-01 | 0.505 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.051176e-01 | 0.688 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.210079e-01 | 0.376 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.539237e-01 | 0.451 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.634125e-01 | 0.579 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.647090e-01 | 0.333 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.434693e-01 | 0.265 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.325667e-01 | 0.478 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.663451e-01 | 0.575 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.517682e-01 | 0.345 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.249595e-01 | 0.488 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.171697e-01 | 0.286 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.562065e-01 | 0.255 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.180870e-01 | 0.209 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.180870e-01 | 0.209 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.909960e-01 | 0.719 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.909960e-01 | 0.719 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.200524e-01 | 0.208 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.771968e-01 | 0.557 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.051176e-01 | 0.688 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.293286e-01 | 0.640 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.562065e-01 | 0.255 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.439331e-01 | 0.464 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.838669e-02 | 1.165 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.436408e-01 | 0.613 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.312651e-01 | 0.275 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.149925e-01 | 0.211 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.827590e-02 | 1.054 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.745447e-01 | 0.758 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.043231e-01 | 0.982 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.955953e-01 | 0.529 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.423660e-01 | 0.616 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.423660e-01 | 0.616 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.478265e-01 | 0.459 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.609451e-01 | 0.583 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.810229e-01 | 0.419 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.062245e-01 | 0.296 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.312651e-01 | 0.275 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.781244e-01 | 0.238 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.180870e-01 | 0.209 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.056402e-01 | 0.515 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.567653e-01 | 0.448 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.274853e-02 | 1.138 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.663197e-01 | 0.575 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.783762e-01 | 0.749 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.477048e-01 | 0.459 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.567439e-01 | 0.805 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.910464e-01 | 0.408 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.634011e-01 | 0.334 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 9.289642e-02 | 1.032 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.325446e-01 | 0.633 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.810229e-01 | 0.419 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.433057e-01 | 0.844 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.943234e-01 | 0.404 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.788285e-01 | 0.237 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.596059e-01 | 0.797 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.083407e-01 | 0.681 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.808940e-01 | 0.551 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.112026e-01 | 0.675 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.286740e-01 | 0.483 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.386285e-01 | 0.622 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.433057e-01 | 0.844 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.755431e-01 | 0.425 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.210079e-01 | 0.376 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.210079e-01 | 0.376 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.210079e-01 | 0.376 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.279593e-01 | 0.642 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.829968e-01 | 0.417 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.714605e-01 | 0.566 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.968886e-01 | 0.706 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.321504e-01 | 0.479 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.831881e-01 | 0.417 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.647090e-01 | 0.333 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.319591e-01 | 0.479 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.008461e-01 | 0.397 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.410858e-01 | 0.355 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.171697e-01 | 0.286 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.459078e-01 | 0.263 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.994077e-01 | 0.222 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.021104e-01 | 0.396 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.113322e-01 | 0.386 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.350023e-01 | 0.272 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.765139e-01 | 0.239 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.180870e-01 | 0.209 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.200524e-01 | 0.208 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.608270e-01 | 0.794 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.639710e-01 | 0.249 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.801056e-01 | 0.553 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.393917e-01 | 0.856 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.460622e-01 | 0.609 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.517757e-01 | 0.599 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.570193e-01 | 0.340 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.818227e-01 | 0.317 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.985426e-01 | 0.223 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.200524e-01 | 0.208 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.374702e-01 | 0.270 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.459427e-02 | 1.024 | 1 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.938834e-01 | 0.712 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.386285e-01 | 0.622 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.517757e-01 | 0.599 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.171697e-01 | 0.286 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.567439e-01 | 0.805 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.400864e-01 | 0.356 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.095183e-01 | 0.509 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.966881e-01 | 0.224 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 7.017193e-02 | 1.154 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.801067e-01 | 0.744 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.940303e-01 | 0.532 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 4.517682e-01 | 0.345 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.520744e-01 | 0.598 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.213024e-01 | 0.916 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.346421e-01 | 0.871 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.724369e-01 | 0.326 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.524484e-02 | 1.185 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.854372e-01 | 0.732 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.210079e-01 | 0.376 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.394121e-01 | 0.621 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.063965e-01 | 0.296 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 3.668140e-01 | 0.436 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.994077e-01 | 0.222 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.133800e-01 | 0.290 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.763632e-01 | 0.239 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.710049e-01 | 0.431 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.721634e-02 | 1.012 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.724369e-01 | 0.326 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.099689e-01 | 0.292 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.435455e-01 | 0.353 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.163605e-01 | 0.381 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.781244e-01 | 0.238 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.551159e-01 | 0.450 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 5.769503e-01 | 0.239 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.870120e-01 | 0.312 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.099689e-01 | 0.292 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.145769e-01 | 0.289 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.063803e-01 | 0.973 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.955576e-01 | 0.529 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.119232e-01 | 0.506 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.533963e-01 | 0.452 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.354697e-01 | 0.868 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.544920e-01 | 0.450 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 4.818227e-01 | 0.317 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.013033e-01 | 0.221 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.409767e-01 | 0.618 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.409767e-01 | 0.618 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.847221e-01 | 0.233 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.544920e-01 | 0.450 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.544920e-01 | 0.450 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.918234e-01 | 0.407 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.204943e-01 | 0.657 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.755431e-01 | 0.425 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.647090e-01 | 0.333 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.146333e-01 | 0.382 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.517682e-01 | 0.345 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.929691e-01 | 0.533 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.569016e-01 | 0.340 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.168113e-01 | 0.210 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.988746e-01 | 0.701 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.380170e-01 | 0.471 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.508707e-01 | 0.259 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.007823e-01 | 0.997 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.555409e-01 | 0.449 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.227343e-01 | 0.491 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.855372e-01 | 0.732 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.067207e-01 | 0.217 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.298971e-01 | 0.886 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.021760e-01 | 0.299 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.779746e-01 | 0.556 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.735498e-01 | 0.325 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.850955e-01 | 0.733 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.568120e-01 | 0.254 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.433958e-02 | 1.074 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.549593e-02 | 1.184 | 1 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.128992e-01 | 0.505 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.366225e-02 | 1.028 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.448069e-01 | 0.839 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.448069e-01 | 0.839 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.663596e-01 | 0.247 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.299763e-01 | 0.638 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.299763e-01 | 0.638 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.438102e-02 | 1.129 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.854372e-01 | 0.732 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.243048e-01 | 0.489 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 9.289642e-02 | 1.032 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.443577e-01 | 0.841 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.356255e-01 | 0.868 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.356255e-01 | 0.868 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.429424e-02 | 1.074 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.807232e-02 | 1.008 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.243239e-01 | 0.905 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.070828e-01 | 0.390 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.070828e-01 | 0.390 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.070828e-01 | 0.390 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.423660e-01 | 0.616 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.459159e-01 | 0.836 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.638547e-01 | 0.786 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.668159e-01 | 0.574 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.797240e-01 | 0.319 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.797240e-01 | 0.319 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.478265e-01 | 0.459 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.651737e-01 | 0.576 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.210079e-01 | 0.376 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.829968e-01 | 0.417 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.915321e-01 | 0.535 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.239979e-02 | 1.205 | 1 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.647090e-01 | 0.333 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.434693e-01 | 0.265 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.434693e-01 | 0.265 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.434693e-01 | 0.265 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.063965e-01 | 0.296 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.063965e-01 | 0.296 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.318924e-01 | 0.365 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.694471e-01 | 0.328 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.861565e-01 | 0.543 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.146333e-01 | 0.382 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.858993e-01 | 0.414 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.171697e-01 | 0.286 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.994077e-01 | 0.222 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.994077e-01 | 0.222 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.313800e-01 | 0.480 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.013805e-01 | 0.300 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.831503e-01 | 0.234 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.038164e-01 | 0.219 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.013033e-01 | 0.221 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.180870e-01 | 0.209 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.174304e-01 | 0.209 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.936337e-01 | 0.226 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.325667e-01 | 0.478 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.535867e-01 | 0.596 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.967112e-01 | 0.224 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.163605e-01 | 0.381 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.246418e-02 | 1.204 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.948604e-01 | 0.404 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.661295e-01 | 0.247 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.125063e-01 | 0.949 | 1 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.283758e-01 | 0.484 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.276856e-01 | 0.278 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.276856e-01 | 0.278 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.924325e-01 | 0.716 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.163605e-01 | 0.381 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.019584e-01 | 0.695 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.794423e-01 | 0.554 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.616335e-01 | 0.791 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.210079e-01 | 0.376 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.517757e-01 | 0.599 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.171697e-01 | 0.286 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.489289e-01 | 0.827 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.157933e-01 | 0.936 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.062245e-01 | 0.296 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.613987e-01 | 0.336 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.779480e-01 | 0.238 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.651923e-01 | 0.782 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.083407e-01 | 0.681 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.083407e-01 | 0.681 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.083407e-01 | 0.681 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.638547e-01 | 0.786 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.755431e-01 | 0.425 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.829968e-01 | 0.417 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 3.829968e-01 | 0.417 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.177167e-01 | 0.379 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.434693e-01 | 0.265 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.122900e-01 | 0.385 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.553219e-01 | 0.449 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.459078e-01 | 0.263 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.180870e-01 | 0.209 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.180870e-01 | 0.209 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.180870e-01 | 0.209 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.587992e-01 | 0.253 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.587992e-01 | 0.253 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.465064e-01 | 0.350 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.542590e-01 | 0.812 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.223546e-01 | 0.282 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.071792e-02 | 1.150 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.161294e-01 | 0.210 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.485392e-01 | 0.828 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.647090e-01 | 0.333 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.013033e-01 | 0.221 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.854838e-01 | 0.732 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.572453e-01 | 0.590 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.345897e-01 | 0.362 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.482519e-01 | 0.261 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.378359e-01 | 0.624 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.318924e-01 | 0.365 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.169752e-01 | 0.287 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.130364e-01 | 0.504 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.243048e-01 | 0.489 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.243239e-01 | 0.905 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.808940e-01 | 0.551 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.070828e-01 | 0.390 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.797240e-01 | 0.319 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 4.210079e-01 | 0.376 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.829968e-01 | 0.417 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.300030e-01 | 0.481 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.177167e-01 | 0.379 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.434693e-01 | 0.265 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.410858e-01 | 0.355 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.459078e-01 | 0.263 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.994077e-01 | 0.222 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.994077e-01 | 0.222 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.559666e-01 | 0.255 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.834731e-01 | 0.234 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.871629e-01 | 0.542 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.249595e-01 | 0.488 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.128992e-01 | 0.505 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.517757e-01 | 0.599 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.687108e-01 | 0.245 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.533622e-01 | 0.596 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.083407e-01 | 0.681 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.386285e-01 | 0.622 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.014048e-01 | 0.696 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.325667e-01 | 0.478 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.063965e-01 | 0.296 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.561385e-01 | 0.806 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.517682e-01 | 0.345 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.246477e-01 | 0.280 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.095809e-01 | 0.388 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.639838e-01 | 0.785 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.755431e-01 | 0.425 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.210079e-01 | 0.376 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.212619e-01 | 0.655 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.434693e-01 | 0.265 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.434693e-01 | 0.265 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.434693e-01 | 0.265 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.994077e-01 | 0.222 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.994077e-01 | 0.222 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.180870e-01 | 0.209 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.291899e-01 | 0.889 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.157933e-01 | 0.936 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.133800e-01 | 0.290 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.067207e-01 | 0.217 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.350023e-01 | 0.272 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.808940e-01 | 0.551 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.771968e-01 | 0.557 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.478265e-01 | 0.459 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.778975e-01 | 0.423 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.994077e-01 | 0.222 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.539237e-01 | 0.451 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.180870e-01 | 0.209 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.829968e-01 | 0.417 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.546889e-01 | 0.256 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.787880e-01 | 0.320 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.787880e-01 | 0.320 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.915321e-01 | 0.535 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.694471e-01 | 0.328 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.832804e-01 | 0.316 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.063965e-01 | 0.296 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.251948e-01 | 0.204 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.272213e-01 | 0.203 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.306297e-01 | 0.200 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.339959e-01 | 0.198 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 6.339959e-01 | 0.198 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.339959e-01 | 0.198 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.339959e-01 | 0.198 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.339959e-01 | 0.198 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.360740e-01 | 0.196 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.399340e-01 | 0.194 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.408618e-01 | 0.193 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.413372e-01 | 0.193 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.469861e-01 | 0.189 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.481553e-01 | 0.188 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.484948e-01 | 0.188 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.484948e-01 | 0.188 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.484948e-01 | 0.188 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.484948e-01 | 0.188 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.484948e-01 | 0.188 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.484948e-01 | 0.188 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.484948e-01 | 0.188 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.484948e-01 | 0.188 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.484948e-01 | 0.188 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.484948e-01 | 0.188 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.484948e-01 | 0.188 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.484948e-01 | 0.188 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.484948e-01 | 0.188 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.484948e-01 | 0.188 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.484948e-01 | 0.188 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.484948e-01 | 0.188 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.484948e-01 | 0.188 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.484948e-01 | 0.188 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.484948e-01 | 0.188 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.484948e-01 | 0.188 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.484948e-01 | 0.188 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.484948e-01 | 0.188 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.484948e-01 | 0.188 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.484948e-01 | 0.188 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 6.507236e-01 | 0.187 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 6.507236e-01 | 0.187 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.507236e-01 | 0.187 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.507236e-01 | 0.187 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.546555e-01 | 0.184 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.573711e-01 | 0.182 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.573711e-01 | 0.182 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.599244e-01 | 0.181 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.599244e-01 | 0.181 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.599244e-01 | 0.181 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.599244e-01 | 0.181 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.599244e-01 | 0.181 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.599244e-01 | 0.181 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.599244e-01 | 0.181 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.609467e-01 | 0.180 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.609467e-01 | 0.180 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.609467e-01 | 0.180 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.656438e-01 | 0.177 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.701620e-01 | 0.174 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.701620e-01 | 0.174 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.701620e-01 | 0.174 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.701620e-01 | 0.174 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.701620e-01 | 0.174 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.701620e-01 | 0.174 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.714751e-01 | 0.173 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.722162e-01 | 0.172 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.726402e-01 | 0.172 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.726402e-01 | 0.172 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.726402e-01 | 0.172 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.726402e-01 | 0.172 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.726402e-01 | 0.172 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.745267e-01 | 0.171 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.784161e-01 | 0.169 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.802893e-01 | 0.167 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.802893e-01 | 0.167 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.802893e-01 | 0.167 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.810992e-01 | 0.167 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.810992e-01 | 0.167 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.810992e-01 | 0.167 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.810992e-01 | 0.167 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.810992e-01 | 0.167 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.810992e-01 | 0.167 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.810992e-01 | 0.167 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.810992e-01 | 0.167 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 6.810992e-01 | 0.167 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.810992e-01 | 0.167 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.834316e-01 | 0.165 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.844965e-01 | 0.165 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.844965e-01 | 0.165 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.844965e-01 | 0.165 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.844965e-01 | 0.165 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.852331e-01 | 0.164 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.852331e-01 | 0.164 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.888332e-01 | 0.162 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.888895e-01 | 0.162 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.900142e-01 | 0.161 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.915695e-01 | 0.160 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.915695e-01 | 0.160 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.915695e-01 | 0.160 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.915695e-01 | 0.160 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.915695e-01 | 0.160 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.915695e-01 | 0.160 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.915695e-01 | 0.160 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.915695e-01 | 0.160 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.915695e-01 | 0.160 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.915695e-01 | 0.160 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.934659e-01 | 0.159 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.951874e-01 | 0.158 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.979005e-01 | 0.156 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.988775e-01 | 0.156 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.992700e-01 | 0.155 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.017622e-01 | 0.154 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.067677e-01 | 0.151 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.067677e-01 | 0.151 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.077167e-01 | 0.150 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.077167e-01 | 0.150 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.077167e-01 | 0.150 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.077167e-01 | 0.150 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.077167e-01 | 0.150 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.077167e-01 | 0.150 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.077167e-01 | 0.150 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 7.092778e-01 | 0.149 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 7.092778e-01 | 0.149 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.092778e-01 | 0.149 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.092778e-01 | 0.149 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.092778e-01 | 0.149 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.092778e-01 | 0.149 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.092778e-01 | 0.149 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.092778e-01 | 0.149 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.092778e-01 | 0.149 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.092778e-01 | 0.149 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.112673e-01 | 0.148 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.116798e-01 | 0.148 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.142781e-01 | 0.146 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.167045e-01 | 0.145 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.221933e-01 | 0.141 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 7.243566e-01 | 0.140 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.244774e-01 | 0.140 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.247795e-01 | 0.140 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.279092e-01 | 0.138 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.293558e-01 | 0.137 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.293558e-01 | 0.137 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.293558e-01 | 0.137 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.293558e-01 | 0.137 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.293678e-01 | 0.137 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.293678e-01 | 0.137 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.293678e-01 | 0.137 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.293678e-01 | 0.137 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.293678e-01 | 0.137 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.293678e-01 | 0.137 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.293678e-01 | 0.137 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.293678e-01 | 0.137 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 7.293678e-01 | 0.137 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 7.293678e-01 | 0.137 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.293678e-01 | 0.137 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.293678e-01 | 0.137 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.293678e-01 | 0.137 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.293678e-01 | 0.137 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.293678e-01 | 0.137 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.293678e-01 | 0.137 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.296012e-01 | 0.137 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.296012e-01 | 0.137 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.296012e-01 | 0.137 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.296012e-01 | 0.137 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.296012e-01 | 0.137 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.303623e-01 | 0.136 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.337684e-01 | 0.134 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.337684e-01 | 0.134 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.337684e-01 | 0.134 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.337684e-01 | 0.134 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.353416e-01 | 0.134 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.353416e-01 | 0.134 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.353416e-01 | 0.134 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.353416e-01 | 0.134 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.353416e-01 | 0.134 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.353416e-01 | 0.134 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 7.353416e-01 | 0.134 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.353416e-01 | 0.134 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.353416e-01 | 0.134 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.353416e-01 | 0.134 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 7.353416e-01 | 0.134 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.354129e-01 | 0.133 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.358604e-01 | 0.133 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.358604e-01 | 0.133 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.435035e-01 | 0.129 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.435953e-01 | 0.129 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.484942e-01 | 0.126 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.500715e-01 | 0.125 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 7.500876e-01 | 0.125 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.501760e-01 | 0.125 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.501760e-01 | 0.125 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 7.532603e-01 | 0.123 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.546120e-01 | 0.122 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.593856e-01 | 0.120 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.593856e-01 | 0.120 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.593856e-01 | 0.120 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.593856e-01 | 0.120 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.593856e-01 | 0.120 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.593856e-01 | 0.120 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.625310e-01 | 0.118 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.625359e-01 | 0.118 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.625359e-01 | 0.118 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.625359e-01 | 0.118 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.625359e-01 | 0.118 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.625359e-01 | 0.118 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.625359e-01 | 0.118 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.625359e-01 | 0.118 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.625359e-01 | 0.118 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.625359e-01 | 0.118 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.625359e-01 | 0.118 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.625359e-01 | 0.118 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.656200e-01 | 0.116 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.656200e-01 | 0.116 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.656200e-01 | 0.116 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.656200e-01 | 0.116 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.656200e-01 | 0.116 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 7.656766e-01 | 0.116 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.656766e-01 | 0.116 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 7.656766e-01 | 0.116 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.665006e-01 | 0.115 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.675025e-01 | 0.115 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.675025e-01 | 0.115 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.694747e-01 | 0.114 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.694747e-01 | 0.114 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.694747e-01 | 0.114 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.704652e-01 | 0.113 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.704652e-01 | 0.113 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.815135e-01 | 0.107 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.815135e-01 | 0.107 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.815135e-01 | 0.107 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.815135e-01 | 0.107 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 7.815135e-01 | 0.107 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.815135e-01 | 0.107 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.819278e-01 | 0.107 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.819278e-01 | 0.107 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.831010e-01 | 0.106 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.831010e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.831010e-01 | 0.106 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.831010e-01 | 0.106 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.831010e-01 | 0.106 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.865002e-01 | 0.104 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.875375e-01 | 0.104 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.875375e-01 | 0.104 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.875375e-01 | 0.104 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.907010e-01 | 0.102 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.916407e-01 | 0.101 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.916407e-01 | 0.101 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.916407e-01 | 0.101 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.916407e-01 | 0.101 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.916407e-01 | 0.101 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.916407e-01 | 0.101 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.916407e-01 | 0.101 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.916407e-01 | 0.101 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.916407e-01 | 0.101 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.916407e-01 | 0.101 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.916407e-01 | 0.101 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.916407e-01 | 0.101 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.916407e-01 | 0.101 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.941334e-01 | 0.100 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.941334e-01 | 0.100 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.941334e-01 | 0.100 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.944946e-01 | 0.100 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.944946e-01 | 0.100 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.972700e-01 | 0.098 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.972700e-01 | 0.098 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.996890e-01 | 0.097 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.018335e-01 | 0.096 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.018335e-01 | 0.096 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.018335e-01 | 0.096 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.018335e-01 | 0.096 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.018335e-01 | 0.096 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.018335e-01 | 0.096 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.018335e-01 | 0.096 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 8.018335e-01 | 0.096 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.018335e-01 | 0.096 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.018335e-01 | 0.096 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.026588e-01 | 0.095 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.044093e-01 | 0.095 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.044093e-01 | 0.095 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.044093e-01 | 0.095 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.044093e-01 | 0.095 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.058236e-01 | 0.094 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.065400e-01 | 0.093 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.068010e-01 | 0.093 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.068010e-01 | 0.093 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.068010e-01 | 0.093 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.075914e-01 | 0.093 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.078484e-01 | 0.093 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.082652e-01 | 0.092 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.088088e-01 | 0.092 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.117288e-01 | 0.091 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.117288e-01 | 0.091 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.117288e-01 | 0.091 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.171797e-01 | 0.088 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.171797e-01 | 0.088 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 8.171797e-01 | 0.088 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.171797e-01 | 0.088 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.171797e-01 | 0.088 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.171797e-01 | 0.088 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.171797e-01 | 0.088 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.171797e-01 | 0.088 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.171797e-01 | 0.088 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.171797e-01 | 0.088 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.171797e-01 | 0.088 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.171797e-01 | 0.088 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.171797e-01 | 0.088 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.171797e-01 | 0.088 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.171797e-01 | 0.088 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.178999e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.183557e-01 | 0.087 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.184963e-01 | 0.087 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.184963e-01 | 0.087 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.201386e-01 | 0.086 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.201386e-01 | 0.086 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.201386e-01 | 0.086 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.204564e-01 | 0.086 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.204564e-01 | 0.086 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.204564e-01 | 0.086 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.204564e-01 | 0.086 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.204564e-01 | 0.086 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.204564e-01 | 0.086 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.205023e-01 | 0.086 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.205023e-01 | 0.086 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.205023e-01 | 0.086 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.284591e-01 | 0.082 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.284591e-01 | 0.082 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.295935e-01 | 0.081 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.303641e-01 | 0.081 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.319609e-01 | 0.080 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.324755e-01 | 0.080 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.324755e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.347766e-01 | 0.078 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.347766e-01 | 0.078 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.374929e-01 | 0.077 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.374929e-01 | 0.077 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.381107e-01 | 0.077 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.393153e-01 | 0.076 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.395896e-01 | 0.076 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 8.395896e-01 | 0.076 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.395896e-01 | 0.076 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.395896e-01 | 0.076 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.395896e-01 | 0.076 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.395896e-01 | 0.076 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.395896e-01 | 0.076 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.395896e-01 | 0.076 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.395896e-01 | 0.076 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.395896e-01 | 0.076 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.395896e-01 | 0.076 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.395896e-01 | 0.076 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 8.395896e-01 | 0.076 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.395896e-01 | 0.076 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.396710e-01 | 0.076 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.406873e-01 | 0.075 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.437200e-01 | 0.074 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.437886e-01 | 0.074 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.437886e-01 | 0.074 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.437886e-01 | 0.074 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.469516e-01 | 0.072 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.471704e-01 | 0.072 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.483760e-01 | 0.071 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.483760e-01 | 0.071 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.500957e-01 | 0.071 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.503949e-01 | 0.070 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.530519e-01 | 0.069 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.530519e-01 | 0.069 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.530519e-01 | 0.069 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.530519e-01 | 0.069 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.530519e-01 | 0.069 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.530519e-01 | 0.069 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.573308e-01 | 0.067 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.592537e-01 | 0.066 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.592537e-01 | 0.066 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.592537e-01 | 0.066 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.592537e-01 | 0.066 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.592537e-01 | 0.066 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.592537e-01 | 0.066 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.592537e-01 | 0.066 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.592537e-01 | 0.066 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.592537e-01 | 0.066 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.592537e-01 | 0.066 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.592537e-01 | 0.066 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.599714e-01 | 0.066 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.609903e-01 | 0.065 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.609903e-01 | 0.065 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.613202e-01 | 0.065 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.613202e-01 | 0.065 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.613202e-01 | 0.065 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.633368e-01 | 0.064 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.659896e-01 | 0.062 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.672396e-01 | 0.062 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.690721e-01 | 0.061 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.718179e-01 | 0.060 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.718179e-01 | 0.060 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.718179e-01 | 0.060 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.726733e-01 | 0.059 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.756034e-01 | 0.058 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.765083e-01 | 0.057 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.765083e-01 | 0.057 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.765083e-01 | 0.057 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.765083e-01 | 0.057 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.765083e-01 | 0.057 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.765083e-01 | 0.057 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.765083e-01 | 0.057 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.765083e-01 | 0.057 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.765083e-01 | 0.057 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.765083e-01 | 0.057 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.765083e-01 | 0.057 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.765083e-01 | 0.057 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.765083e-01 | 0.057 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.765083e-01 | 0.057 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.801583e-01 | 0.055 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.801583e-01 | 0.055 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.801583e-01 | 0.055 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.801583e-01 | 0.055 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.816226e-01 | 0.055 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.816226e-01 | 0.055 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.816226e-01 | 0.055 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.816226e-01 | 0.055 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.828917e-01 | 0.054 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.828917e-01 | 0.054 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.828917e-01 | 0.054 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.834781e-01 | 0.054 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.834781e-01 | 0.054 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.868161e-01 | 0.052 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.868161e-01 | 0.052 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.876980e-01 | 0.052 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.894799e-01 | 0.051 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.904644e-01 | 0.050 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.912483e-01 | 0.050 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.912483e-01 | 0.050 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.916485e-01 | 0.050 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.916485e-01 | 0.050 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.916485e-01 | 0.050 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.916485e-01 | 0.050 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.916485e-01 | 0.050 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.916485e-01 | 0.050 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.916485e-01 | 0.050 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.916485e-01 | 0.050 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.916485e-01 | 0.050 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.916485e-01 | 0.050 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.916485e-01 | 0.050 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.916485e-01 | 0.050 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.916485e-01 | 0.050 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.916485e-01 | 0.050 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.916485e-01 | 0.050 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.916485e-01 | 0.050 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.916848e-01 | 0.050 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.919059e-01 | 0.050 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.919059e-01 | 0.050 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.919059e-01 | 0.050 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.934122e-01 | 0.049 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.934122e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.934573e-01 | 0.049 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.934573e-01 | 0.049 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.934573e-01 | 0.049 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 8.951569e-01 | 0.048 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.979552e-01 | 0.047 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.985499e-01 | 0.046 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.990855e-01 | 0.046 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.992890e-01 | 0.046 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.006185e-01 | 0.045 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.025753e-01 | 0.045 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.025753e-01 | 0.045 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.025753e-01 | 0.045 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.025753e-01 | 0.045 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.026621e-01 | 0.044 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.026621e-01 | 0.044 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.026621e-01 | 0.044 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.026621e-01 | 0.044 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.036426e-01 | 0.044 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.049332e-01 | 0.043 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.049332e-01 | 0.043 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.049332e-01 | 0.043 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.049332e-01 | 0.043 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.049332e-01 | 0.043 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.049332e-01 | 0.043 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.049332e-01 | 0.043 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.056807e-01 | 0.043 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.064277e-01 | 0.043 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.064786e-01 | 0.043 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.094057e-01 | 0.041 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.111421e-01 | 0.040 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.111421e-01 | 0.040 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.111421e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.111421e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.122542e-01 | 0.040 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.122542e-01 | 0.040 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.131110e-01 | 0.039 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.145874e-01 | 0.039 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.145874e-01 | 0.039 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.149698e-01 | 0.039 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.153245e-01 | 0.038 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.158952e-01 | 0.038 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.165898e-01 | 0.038 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.165898e-01 | 0.038 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.165898e-01 | 0.038 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.165898e-01 | 0.038 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.165898e-01 | 0.038 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.165898e-01 | 0.038 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.165898e-01 | 0.038 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.165898e-01 | 0.038 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.189452e-01 | 0.037 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.189452e-01 | 0.037 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.189555e-01 | 0.037 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.200770e-01 | 0.036 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.202308e-01 | 0.036 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.202308e-01 | 0.036 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.209064e-01 | 0.036 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.210250e-01 | 0.036 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.210250e-01 | 0.036 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.210250e-01 | 0.036 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.210250e-01 | 0.036 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.214298e-01 | 0.036 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.227345e-01 | 0.035 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.228649e-01 | 0.035 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.236857e-01 | 0.034 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.254017e-01 | 0.034 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.261175e-01 | 0.033 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.261175e-01 | 0.033 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.261661e-01 | 0.033 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.268177e-01 | 0.033 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.268177e-01 | 0.033 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.268177e-01 | 0.033 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 9.268177e-01 | 0.033 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.268177e-01 | 0.033 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.268177e-01 | 0.033 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.268177e-01 | 0.033 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.276182e-01 | 0.033 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.277760e-01 | 0.033 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.289649e-01 | 0.032 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.289649e-01 | 0.032 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.289649e-01 | 0.032 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.289649e-01 | 0.032 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.289649e-01 | 0.032 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.289649e-01 | 0.032 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.293459e-01 | 0.032 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.305701e-01 | 0.031 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.306778e-01 | 0.031 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.336559e-01 | 0.030 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.336559e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.357920e-01 | 0.029 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.357920e-01 | 0.029 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.357920e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.357920e-01 | 0.029 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.357920e-01 | 0.029 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 9.357920e-01 | 0.029 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.357920e-01 | 0.029 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.357920e-01 | 0.029 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.357920e-01 | 0.029 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.357920e-01 | 0.029 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.357920e-01 | 0.029 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.361458e-01 | 0.029 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.361458e-01 | 0.029 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.365354e-01 | 0.028 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.365354e-01 | 0.028 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.369243e-01 | 0.028 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.387434e-01 | 0.027 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.387434e-01 | 0.027 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.395902e-01 | 0.027 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.413942e-01 | 0.026 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.426342e-01 | 0.026 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.426342e-01 | 0.026 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.426342e-01 | 0.026 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.436662e-01 | 0.025 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.436662e-01 | 0.025 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.436662e-01 | 0.025 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.436662e-01 | 0.025 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.436662e-01 | 0.025 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.436662e-01 | 0.025 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.436662e-01 | 0.025 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.436662e-01 | 0.025 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.436662e-01 | 0.025 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 9.442786e-01 | 0.025 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.446506e-01 | 0.025 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.448526e-01 | 0.025 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.459152e-01 | 0.024 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.460537e-01 | 0.024 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.467008e-01 | 0.024 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.484921e-01 | 0.023 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.484921e-01 | 0.023 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.484921e-01 | 0.023 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.484921e-01 | 0.023 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.493460e-01 | 0.023 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.493460e-01 | 0.023 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.493460e-01 | 0.023 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.494665e-01 | 0.023 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.499726e-01 | 0.022 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.502826e-01 | 0.022 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.505752e-01 | 0.022 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.505752e-01 | 0.022 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.505752e-01 | 0.022 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.505752e-01 | 0.022 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.505752e-01 | 0.022 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.505752e-01 | 0.022 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.505752e-01 | 0.022 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.517432e-01 | 0.021 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.517570e-01 | 0.021 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.537765e-01 | 0.021 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.537765e-01 | 0.021 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.537765e-01 | 0.021 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.537765e-01 | 0.021 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.537765e-01 | 0.021 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.539810e-01 | 0.020 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.551339e-01 | 0.020 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.566372e-01 | 0.019 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.566372e-01 | 0.019 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.566372e-01 | 0.019 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.567769e-01 | 0.019 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.570331e-01 | 0.019 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.576659e-01 | 0.019 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.582169e-01 | 0.019 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.585399e-01 | 0.018 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.592148e-01 | 0.018 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.604038e-01 | 0.018 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.619559e-01 | 0.017 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.619559e-01 | 0.017 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.619559e-01 | 0.017 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.619559e-01 | 0.017 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.619559e-01 | 0.017 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.619559e-01 | 0.017 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.619559e-01 | 0.017 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.620849e-01 | 0.017 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.628305e-01 | 0.016 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.638126e-01 | 0.016 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.638187e-01 | 0.016 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.640405e-01 | 0.016 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.640405e-01 | 0.016 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.656140e-01 | 0.015 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.666226e-01 | 0.015 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.666226e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.666226e-01 | 0.015 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.666226e-01 | 0.015 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.666226e-01 | 0.015 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.666226e-01 | 0.015 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.666226e-01 | 0.015 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.666226e-01 | 0.015 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.666927e-01 | 0.015 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.666927e-01 | 0.015 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.666927e-01 | 0.015 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.671313e-01 | 0.015 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.671313e-01 | 0.015 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.688317e-01 | 0.014 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.688317e-01 | 0.014 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.699730e-01 | 0.013 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.699730e-01 | 0.013 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.701669e-01 | 0.013 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.701669e-01 | 0.013 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.706018e-01 | 0.013 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.707171e-01 | 0.013 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.707171e-01 | 0.013 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.707171e-01 | 0.013 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.707171e-01 | 0.013 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.707171e-01 | 0.013 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.723001e-01 | 0.012 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.725412e-01 | 0.012 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.725836e-01 | 0.012 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 9.732903e-01 | 0.012 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.732903e-01 | 0.012 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.743095e-01 | 0.011 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.743095e-01 | 0.011 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.743095e-01 | 0.011 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.743095e-01 | 0.011 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.743095e-01 | 0.011 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.749803e-01 | 0.011 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.765244e-01 | 0.010 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.768598e-01 | 0.010 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.768598e-01 | 0.010 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.771792e-01 | 0.010 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.771792e-01 | 0.010 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.774092e-01 | 0.010 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.774613e-01 | 0.010 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.774613e-01 | 0.010 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.774613e-01 | 0.010 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.774613e-01 | 0.010 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.774613e-01 | 0.010 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.774613e-01 | 0.010 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.774613e-01 | 0.010 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.774613e-01 | 0.010 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.776852e-01 | 0.010 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.784751e-01 | 0.009 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.785539e-01 | 0.009 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.786165e-01 | 0.009 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 9.786165e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.786165e-01 | 0.009 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.786165e-01 | 0.009 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.786165e-01 | 0.009 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.789500e-01 | 0.009 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.790673e-01 | 0.009 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.791952e-01 | 0.009 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.791952e-01 | 0.009 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.802267e-01 | 0.009 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.802267e-01 | 0.009 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.802267e-01 | 0.009 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.802267e-01 | 0.009 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.802267e-01 | 0.009 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.802267e-01 | 0.009 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.802267e-01 | 0.009 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.802267e-01 | 0.009 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.806534e-01 | 0.008 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.808781e-01 | 0.008 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.813016e-01 | 0.008 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.815524e-01 | 0.008 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.816742e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.820102e-01 | 0.008 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.826529e-01 | 0.008 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.826529e-01 | 0.008 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.826529e-01 | 0.008 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.826529e-01 | 0.008 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.826529e-01 | 0.008 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.826529e-01 | 0.008 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.826529e-01 | 0.008 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.829068e-01 | 0.007 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.831416e-01 | 0.007 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.847257e-01 | 0.007 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 9.847257e-01 | 0.007 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.847815e-01 | 0.007 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.847815e-01 | 0.007 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.847815e-01 | 0.007 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.847815e-01 | 0.007 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.847815e-01 | 0.007 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.859791e-01 | 0.006 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.863557e-01 | 0.006 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.866490e-01 | 0.006 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.866490e-01 | 0.006 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.866490e-01 | 0.006 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.867924e-01 | 0.006 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.867924e-01 | 0.006 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.878159e-01 | 0.005 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.882875e-01 | 0.005 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.884094e-01 | 0.005 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.886365e-01 | 0.005 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.887521e-01 | 0.005 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.889029e-01 | 0.005 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.891232e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.891232e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.892513e-01 | 0.005 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.893895e-01 | 0.005 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.897250e-01 | 0.004 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.897250e-01 | 0.004 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.897250e-01 | 0.004 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.897514e-01 | 0.004 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.902933e-01 | 0.004 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.903069e-01 | 0.004 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.905186e-01 | 0.004 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.906046e-01 | 0.004 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.906046e-01 | 0.004 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.906444e-01 | 0.004 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.909861e-01 | 0.004 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.913401e-01 | 0.004 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.916734e-01 | 0.004 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.919526e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.920478e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.920478e-01 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.920478e-01 | 0.003 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.920925e-01 | 0.003 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.920925e-01 | 0.003 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.920925e-01 | 0.003 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.920925e-01 | 0.003 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.922762e-01 | 0.003 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.924988e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.928477e-01 | 0.003 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.930631e-01 | 0.003 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.931131e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.932447e-01 | 0.003 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.938609e-01 | 0.003 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.938609e-01 | 0.003 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.939147e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.942008e-01 | 0.003 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.945585e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.945585e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.946617e-01 | 0.002 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.949094e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.949503e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.950764e-01 | 0.002 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.951256e-01 | 0.002 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.953171e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.953171e-01 | 0.002 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.953171e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.953171e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.953171e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.953171e-01 | 0.002 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.953171e-01 | 0.002 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.953171e-01 | 0.002 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.953171e-01 | 0.002 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.958921e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.958921e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.958921e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.959577e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.959577e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.959577e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.959577e-01 | 0.002 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.960244e-01 | 0.002 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.961560e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.963415e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.963965e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.963965e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.964219e-01 | 0.002 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.964772e-01 | 0.002 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.965809e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.967850e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.967850e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.968390e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.968390e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.969360e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.970062e-01 | 0.001 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.971100e-01 | 0.001 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.972272e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.972272e-01 | 0.001 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.972272e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.972334e-01 | 0.001 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.975584e-01 | 0.001 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.975677e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.975677e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.976718e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.978662e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.978664e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.978664e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.978664e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.979105e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.979105e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.981285e-01 | 0.001 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.981358e-01 | 0.001 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.982935e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.983613e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.983716e-01 | 0.001 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.984217e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.985302e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.985600e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.985600e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.986516e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.986516e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.987363e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.987369e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.988017e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.988357e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.988921e-01 | 0.000 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.988921e-01 | 0.000 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.989353e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.990145e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.990282e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.991476e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.992641e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.992761e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.993442e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.994248e-01 | 0.000 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.994248e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.994780e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.994955e-01 | 0.000 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.995362e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.995575e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.995889e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.996082e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996352e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.996405e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.996764e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.996890e-01 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.996925e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997130e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.997381e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.997454e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.997703e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.997714e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.998371e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998383e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998427e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.998450e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.998450e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998545e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998641e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.998808e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.998808e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999077e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999083e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999157e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999196e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999196e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999295e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999338e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999338e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999458e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999526e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999586e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999671e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999696e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999707e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999719e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999753e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999810e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999819e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999822e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999856e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999878e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999888e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999888e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999896e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999903e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999905e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999914e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999916e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999942e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999945e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999948e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.999970e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999978e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999978e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999980e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999981e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999984e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999990e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999991e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.999994e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999996e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999996e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 1 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 4.440892e-16 | 15.353 | 1 | 0 |
| M Phase | R-HSA-68886 | 1.554312e-15 | 14.808 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.465494e-14 | 13.834 | 1 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.030909e-14 | 13.518 | 1 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.899725e-13 | 12.229 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.295852e-12 | 11.887 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.024736e-12 | 11.220 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.593925e-11 | 10.798 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.327727e-11 | 10.364 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.403178e-11 | 10.267 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.190151e-10 | 9.496 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.951534e-10 | 9.305 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.505622e-10 | 9.259 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.547343e-10 | 9.184 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.547043e-10 | 9.184 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.469190e-10 | 9.072 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.562061e-10 | 9.067 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.458617e-10 | 9.073 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.007496e-09 | 8.997 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.254452e-09 | 8.902 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.225266e-09 | 8.912 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.378897e-09 | 8.860 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.698282e-09 | 8.770 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.350332e-09 | 8.629 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.479478e-09 | 8.606 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.868836e-09 | 8.542 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.993183e-09 | 8.524 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.215415e-09 | 8.493 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.492476e-09 | 8.457 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.961122e-09 | 8.402 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.326764e-09 | 8.364 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.043782e-09 | 8.297 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.774238e-09 | 8.169 | 1 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.144589e-09 | 8.146 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.840702e-09 | 8.106 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 8.347772e-09 | 8.078 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.253635e-08 | 7.902 | 1 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.259255e-08 | 7.900 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.423160e-08 | 7.847 | 1 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.418060e-08 | 7.848 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.418060e-08 | 7.848 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.510137e-08 | 7.821 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.898915e-08 | 7.721 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.009950e-08 | 7.697 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.082306e-08 | 7.681 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.044739e-08 | 7.689 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.100050e-08 | 7.678 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.455023e-08 | 7.610 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.433309e-08 | 7.614 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.603109e-08 | 7.585 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.822453e-08 | 7.549 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.118955e-08 | 7.506 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.899567e-08 | 7.409 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.823773e-08 | 7.418 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.123536e-08 | 7.385 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.298182e-08 | 7.201 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.353688e-08 | 7.197 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.036436e-08 | 7.153 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.780897e-08 | 7.056 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.111799e-07 | 6.954 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.250175e-07 | 6.903 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.403305e-07 | 6.853 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.400691e-07 | 6.854 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.428969e-07 | 6.845 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.779410e-07 | 6.750 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.930077e-07 | 6.714 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.049500e-07 | 6.688 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.649512e-07 | 6.577 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.144918e-07 | 6.502 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.264559e-07 | 6.486 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.748384e-07 | 6.426 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.063722e-07 | 6.391 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.867359e-07 | 6.313 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.206720e-07 | 6.283 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.435034e-07 | 6.191 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.684310e-07 | 6.175 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.051383e-07 | 6.094 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.051383e-07 | 6.094 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.035275e-06 | 5.985 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.603497e-06 | 5.795 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.603497e-06 | 5.795 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.575459e-06 | 5.803 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.648778e-06 | 5.783 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.918946e-06 | 5.717 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.919175e-06 | 5.717 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.919175e-06 | 5.717 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.314318e-06 | 5.636 | 1 | 0 |
| DNA Replication | R-HSA-69306 | 2.585627e-06 | 5.587 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.673472e-06 | 5.573 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.096583e-06 | 5.509 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.096583e-06 | 5.509 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.300231e-06 | 5.481 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.492463e-06 | 5.457 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.722104e-06 | 5.429 | 1 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.792230e-06 | 5.421 | 1 | 1 |
| Influenza Infection | R-HSA-168255 | 3.841040e-06 | 5.416 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.940447e-06 | 5.404 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.337497e-06 | 5.363 | 1 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.337497e-06 | 5.363 | 1 | 1 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.402004e-06 | 5.356 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 4.665343e-06 | 5.331 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.998900e-06 | 5.301 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.998900e-06 | 5.301 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.366319e-06 | 5.270 | 1 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.077511e-06 | 5.294 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.933342e-06 | 5.227 | 0 | 0 |
| Depurination | R-HSA-73927 | 6.071808e-06 | 5.217 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.705008e-06 | 5.174 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.785241e-06 | 5.168 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.136456e-06 | 5.147 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.429718e-06 | 5.129 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 7.487018e-06 | 5.126 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.844164e-06 | 5.105 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.098019e-06 | 5.092 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.813869e-06 | 5.055 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.281699e-06 | 5.032 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.831556e-06 | 5.007 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.006255e-05 | 4.997 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.017690e-05 | 4.992 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.017690e-05 | 4.992 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.102301e-05 | 4.958 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.220199e-05 | 4.914 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.220199e-05 | 4.914 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.220199e-05 | 4.914 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.390522e-05 | 4.857 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.463560e-05 | 4.835 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.028636e-05 | 4.693 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.033570e-05 | 4.692 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.168369e-05 | 4.664 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.170971e-05 | 4.663 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.233914e-05 | 4.651 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.410731e-05 | 4.618 | 1 | 1 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.427654e-05 | 4.615 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.473808e-05 | 4.607 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.537631e-05 | 4.596 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.801622e-05 | 4.553 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.153195e-05 | 4.501 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.196549e-05 | 4.495 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.577401e-05 | 4.446 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.744537e-05 | 4.427 | 1 | 1 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.214609e-05 | 4.375 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.971816e-05 | 4.401 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.971816e-05 | 4.401 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.868947e-05 | 4.412 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.325366e-05 | 4.364 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.378383e-05 | 4.359 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.883260e-05 | 4.311 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.955221e-05 | 4.305 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.364423e-05 | 4.270 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.803887e-05 | 4.236 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.450927e-05 | 4.190 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.736119e-05 | 4.172 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 6.755823e-05 | 4.170 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.525083e-05 | 4.123 | 1 | 1 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.981133e-05 | 4.047 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.194120e-05 | 4.036 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.014670e-04 | 3.994 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.153408e-04 | 3.938 | 1 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.263982e-04 | 3.898 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.271576e-04 | 3.896 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.307485e-04 | 3.884 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.362054e-04 | 3.866 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.564055e-04 | 3.806 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.611167e-04 | 3.793 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.641364e-04 | 3.785 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.661868e-04 | 3.779 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.682724e-04 | 3.774 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.810400e-04 | 3.742 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.839048e-04 | 3.735 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.135267e-04 | 3.671 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.064684e-04 | 3.685 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.135834e-04 | 3.670 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.997209e-04 | 3.700 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.135267e-04 | 3.671 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.901303e-04 | 3.721 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.310886e-04 | 3.636 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.399944e-04 | 3.620 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.472447e-04 | 3.607 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.547854e-04 | 3.594 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.585544e-04 | 3.587 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.686740e-04 | 3.571 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.686740e-04 | 3.571 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.699217e-04 | 3.569 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.949193e-04 | 3.530 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.123889e-04 | 3.505 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.425151e-04 | 3.465 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.664847e-04 | 3.436 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.785698e-04 | 3.422 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.806657e-04 | 3.419 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.926944e-04 | 3.406 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.926944e-04 | 3.406 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.154769e-04 | 3.381 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.266683e-04 | 3.370 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.052553e-04 | 3.392 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.222289e-04 | 3.374 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.494225e-04 | 3.347 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.922443e-04 | 3.308 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.968766e-04 | 3.304 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.983944e-04 | 3.302 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.110274e-04 | 3.292 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.320226e-04 | 3.274 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.555046e-04 | 3.255 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.555046e-04 | 3.255 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.920362e-04 | 3.228 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.929318e-04 | 3.227 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.567745e-04 | 3.183 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.655772e-04 | 3.177 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.666989e-04 | 3.176 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.438599e-04 | 3.129 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.305721e-04 | 3.081 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.463454e-04 | 3.072 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.463454e-04 | 3.072 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.649015e-04 | 3.063 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.023382e-03 | 2.990 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.023382e-03 | 2.990 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.970056e-04 | 3.047 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 8.970056e-04 | 3.047 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.023382e-03 | 2.990 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.139413e-04 | 3.039 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.029523e-04 | 3.044 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.029523e-04 | 3.044 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.023382e-03 | 2.990 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.026146e-03 | 2.989 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.027550e-03 | 2.988 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.084890e-03 | 2.965 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.084890e-03 | 2.965 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.084890e-03 | 2.965 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.092909e-03 | 2.961 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.095935e-03 | 2.960 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.218463e-03 | 2.914 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.263287e-03 | 2.898 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.368569e-03 | 2.864 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.370859e-03 | 2.863 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.370859e-03 | 2.863 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.381635e-03 | 2.860 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.436634e-03 | 2.843 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.436634e-03 | 2.843 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.436634e-03 | 2.843 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.549861e-03 | 2.810 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.569142e-03 | 2.804 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.661636e-03 | 2.779 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.810151e-03 | 2.742 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.954291e-03 | 2.709 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.855541e-03 | 2.732 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.113781e-03 | 2.675 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.113781e-03 | 2.675 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.147129e-03 | 2.668 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.891316e-03 | 2.723 | 1 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.147129e-03 | 2.668 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.159313e-03 | 2.666 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.173620e-03 | 2.663 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.173620e-03 | 2.663 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.173620e-03 | 2.663 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.173620e-03 | 2.663 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.299457e-03 | 2.638 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.302271e-03 | 2.638 | 1 | 1 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.428840e-03 | 2.615 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.497394e-03 | 2.603 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.509125e-03 | 2.600 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.509125e-03 | 2.600 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.560707e-03 | 2.592 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.614514e-03 | 2.583 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.747040e-03 | 2.561 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.796664e-03 | 2.553 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.801042e-03 | 2.553 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.889045e-03 | 2.539 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.918915e-03 | 2.535 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.918915e-03 | 2.535 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.956310e-03 | 2.529 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.117087e-03 | 2.506 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.589579e-03 | 2.445 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.733650e-03 | 2.428 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.748875e-03 | 2.426 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 3.748875e-03 | 2.426 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.748875e-03 | 2.426 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.899745e-03 | 2.409 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.368642e-03 | 2.360 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.368642e-03 | 2.360 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.368642e-03 | 2.360 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.368642e-03 | 2.360 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.642400e-03 | 2.333 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.153983e-03 | 2.382 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.153983e-03 | 2.382 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.999020e-03 | 2.301 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 4.850967e-03 | 2.314 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.106150e-03 | 2.387 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.188866e-03 | 2.378 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.106150e-03 | 2.387 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.800531e-03 | 2.319 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.850967e-03 | 2.314 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.480192e-03 | 2.349 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.714414e-03 | 2.327 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.398586e-03 | 2.357 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.398586e-03 | 2.357 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 4.288956e-03 | 2.368 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 4.288956e-03 | 2.368 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 4.810501e-03 | 2.318 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.058151e-03 | 2.296 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.127223e-03 | 2.290 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.127223e-03 | 2.290 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.127223e-03 | 2.290 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.127223e-03 | 2.290 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.127223e-03 | 2.290 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.127223e-03 | 2.290 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.246312e-03 | 2.280 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.708577e-03 | 2.243 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.833751e-03 | 2.234 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.833751e-03 | 2.234 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.833751e-03 | 2.234 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.888149e-03 | 2.230 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.432081e-03 | 2.192 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.658744e-03 | 2.177 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.699738e-03 | 2.174 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.834171e-03 | 2.165 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.947964e-03 | 2.158 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 6.947964e-03 | 2.158 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.037467e-03 | 2.153 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.317498e-03 | 2.136 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.396107e-03 | 2.131 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 7.742184e-03 | 2.111 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.901079e-03 | 2.102 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.901079e-03 | 2.102 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.901079e-03 | 2.102 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.901079e-03 | 2.102 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 8.271647e-03 | 2.082 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.376445e-03 | 2.077 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.376445e-03 | 2.077 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.376445e-03 | 2.077 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.960466e-03 | 2.048 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.130785e-03 | 2.039 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.130785e-03 | 2.039 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.239379e-03 | 2.034 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.239379e-03 | 2.034 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.239379e-03 | 2.034 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.518785e-03 | 2.021 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 9.748719e-03 | 2.011 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.006782e-02 | 1.997 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.013334e-02 | 1.994 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.021740e-02 | 1.991 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.022694e-02 | 1.990 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.070320e-02 | 1.970 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.108756e-02 | 1.955 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.163780e-02 | 1.934 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.163780e-02 | 1.934 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.163780e-02 | 1.934 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.163780e-02 | 1.934 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.163780e-02 | 1.934 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.170503e-02 | 1.932 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.170503e-02 | 1.932 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.186385e-02 | 1.926 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.238123e-02 | 1.907 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.271055e-02 | 1.896 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.271055e-02 | 1.896 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.691823e-02 | 1.772 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.298294e-02 | 1.887 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.414442e-02 | 1.849 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.691823e-02 | 1.772 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.506941e-02 | 1.822 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.629441e-02 | 1.788 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.691823e-02 | 1.772 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.691712e-02 | 1.772 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.571664e-02 | 1.804 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.691712e-02 | 1.772 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.623549e-02 | 1.790 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.691823e-02 | 1.772 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.629441e-02 | 1.788 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.271055e-02 | 1.896 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.620098e-02 | 1.790 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.440948e-02 | 1.841 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.283752e-02 | 1.892 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.271055e-02 | 1.896 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.723822e-02 | 1.764 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.817978e-02 | 1.740 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.882715e-02 | 1.725 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.890013e-02 | 1.724 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.990977e-02 | 1.701 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.063191e-02 | 1.685 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.178446e-02 | 1.662 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.178446e-02 | 1.662 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.190411e-02 | 1.659 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.190411e-02 | 1.659 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.256396e-02 | 1.647 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.353847e-02 | 1.628 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.353847e-02 | 1.628 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.421650e-02 | 1.616 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.421650e-02 | 1.616 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.421650e-02 | 1.616 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.421650e-02 | 1.616 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.421650e-02 | 1.616 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.484161e-02 | 1.605 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.496018e-02 | 1.603 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.717891e-02 | 1.566 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.742117e-02 | 1.562 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.763227e-02 | 1.559 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.843911e-02 | 1.546 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.889637e-02 | 1.539 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.908867e-02 | 1.536 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.223210e-02 | 1.492 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.223210e-02 | 1.492 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.329390e-02 | 1.478 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 3.421301e-02 | 1.466 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 3.421301e-02 | 1.466 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.472061e-02 | 1.459 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.501469e-02 | 1.456 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.571683e-02 | 1.447 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.634889e-02 | 1.440 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.634889e-02 | 1.440 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.640225e-02 | 1.439 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.668209e-02 | 1.436 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.687829e-02 | 1.433 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.687829e-02 | 1.433 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.712390e-02 | 1.430 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.828609e-02 | 1.417 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.850969e-02 | 1.414 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.880677e-02 | 1.411 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.899751e-02 | 1.409 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.009780e-02 | 1.397 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.009780e-02 | 1.397 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.009780e-02 | 1.397 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.044367e-02 | 1.393 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.079809e-02 | 1.389 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.079809e-02 | 1.389 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.079809e-02 | 1.389 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.079809e-02 | 1.389 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.152344e-02 | 1.382 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.156948e-02 | 1.381 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.179533e-02 | 1.379 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.179533e-02 | 1.379 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 4.179533e-02 | 1.379 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 4.179533e-02 | 1.379 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 4.179533e-02 | 1.379 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 4.179533e-02 | 1.379 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.191244e-02 | 1.378 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.238437e-02 | 1.373 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.259793e-02 | 1.371 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.656016e-02 | 1.332 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.755426e-02 | 1.323 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.806423e-02 | 1.318 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.806423e-02 | 1.318 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.823833e-02 | 1.317 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 6.217418e-02 | 1.206 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 6.217418e-02 | 1.206 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.039680e-02 | 1.219 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.039680e-02 | 1.219 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.404793e-02 | 1.130 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.926346e-02 | 1.227 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.306854e-02 | 1.275 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.638114e-02 | 1.178 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.370375e-02 | 1.133 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.522489e-02 | 1.186 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.522489e-02 | 1.186 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 7.319194e-02 | 1.136 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 5.072203e-02 | 1.295 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.956627e-02 | 1.158 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.370375e-02 | 1.133 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.360551e-02 | 1.271 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.404793e-02 | 1.130 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.944757e-02 | 1.158 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.039680e-02 | 1.219 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.924286e-02 | 1.160 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.010974e-02 | 1.300 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.705827e-02 | 1.174 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.306854e-02 | 1.275 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.439100e-02 | 1.264 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.926346e-02 | 1.227 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.924286e-02 | 1.160 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.620778e-02 | 1.250 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.665276e-02 | 1.247 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.548876e-02 | 1.184 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 5.010974e-02 | 1.300 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.731071e-02 | 1.242 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.199724e-02 | 1.284 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.821462e-02 | 1.166 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 5.072203e-02 | 1.295 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.072203e-02 | 1.295 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.404793e-02 | 1.130 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.548876e-02 | 1.184 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.522489e-02 | 1.186 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.533803e-02 | 1.257 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.707455e-02 | 1.244 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.944757e-02 | 1.158 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.924286e-02 | 1.160 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.924286e-02 | 1.160 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.705827e-02 | 1.174 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.230084e-02 | 1.281 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.123539e-02 | 1.213 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.190617e-02 | 1.285 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.618968e-02 | 1.250 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.714913e-02 | 1.243 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.876198e-02 | 1.231 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.411262e-02 | 1.130 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.479885e-02 | 1.126 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.776457e-02 | 1.109 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.798306e-02 | 1.108 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.798306e-02 | 1.108 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.798306e-02 | 1.108 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.002734e-02 | 1.097 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.002734e-02 | 1.097 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.002734e-02 | 1.097 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 8.002734e-02 | 1.097 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.030912e-02 | 1.095 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.030912e-02 | 1.095 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.146828e-02 | 1.089 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.146828e-02 | 1.089 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.160619e-02 | 1.088 | 0 | 0 |
| Translation | R-HSA-72766 | 8.466422e-02 | 1.072 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 8.503199e-02 | 1.070 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 8.503199e-02 | 1.070 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 8.503199e-02 | 1.070 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 8.503199e-02 | 1.070 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.853296e-02 | 1.053 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.893102e-02 | 1.051 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 8.893102e-02 | 1.051 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 8.893102e-02 | 1.051 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.897717e-02 | 1.051 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.159016e-02 | 1.038 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.159016e-02 | 1.038 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.159016e-02 | 1.038 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 9.168930e-02 | 1.038 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.359579e-02 | 1.029 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.359579e-02 | 1.029 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.600240e-02 | 1.018 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.750308e-02 | 1.011 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.038380e-01 | 0.984 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.038380e-01 | 0.984 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.038380e-01 | 0.984 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.038858e-01 | 0.983 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.038992e-01 | 0.983 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.038992e-01 | 0.983 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.045645e-01 | 0.981 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.045645e-01 | 0.981 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.045645e-01 | 0.981 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.045645e-01 | 0.981 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.075700e-01 | 0.968 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.079536e-01 | 0.967 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.099639e-01 | 0.959 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.099639e-01 | 0.959 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.099639e-01 | 0.959 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.099639e-01 | 0.959 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.099639e-01 | 0.959 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.099639e-01 | 0.959 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.157301e-01 | 0.937 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.157301e-01 | 0.937 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.168332e-01 | 0.932 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.168332e-01 | 0.932 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.168332e-01 | 0.932 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.168332e-01 | 0.932 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.168332e-01 | 0.932 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.168332e-01 | 0.932 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.168722e-01 | 0.932 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.169176e-01 | 0.932 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.215231e-01 | 0.915 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.215231e-01 | 0.915 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.220037e-01 | 0.914 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.236821e-01 | 0.908 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.236821e-01 | 0.908 | 1 | 1 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.236821e-01 | 0.908 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.236821e-01 | 0.908 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.237141e-01 | 0.908 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.242299e-01 | 0.906 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.303992e-01 | 0.885 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.303992e-01 | 0.885 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.303992e-01 | 0.885 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.304997e-01 | 0.884 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.304997e-01 | 0.884 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.304997e-01 | 0.884 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.306050e-01 | 0.884 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.306050e-01 | 0.884 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.306050e-01 | 0.884 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.486856e-01 | 0.828 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.486856e-01 | 0.828 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.486856e-01 | 0.828 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.145262e-01 | 0.669 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.145262e-01 | 0.669 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.145262e-01 | 0.669 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.365129e-01 | 0.865 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.365129e-01 | 0.865 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.365129e-01 | 0.865 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.642803e-01 | 0.784 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.642803e-01 | 0.784 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.929193e-01 | 0.715 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.929193e-01 | 0.715 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.929193e-01 | 0.715 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.399857e-01 | 0.854 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.399857e-01 | 0.854 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.399857e-01 | 0.854 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.399857e-01 | 0.854 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.399857e-01 | 0.854 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.399857e-01 | 0.854 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.399857e-01 | 0.854 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.516511e-01 | 0.599 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.516511e-01 | 0.599 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.984362e-01 | 0.702 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.190723e-01 | 0.659 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.190723e-01 | 0.659 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.423515e-01 | 0.847 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.423515e-01 | 0.847 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.423515e-01 | 0.847 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.423515e-01 | 0.847 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.547581e-01 | 0.810 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.911360e-01 | 0.719 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.614782e-01 | 0.583 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.808291e-01 | 0.743 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.241896e-01 | 0.649 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.494049e-01 | 0.826 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.816262e-01 | 0.741 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.816262e-01 | 0.741 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.816262e-01 | 0.741 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.404167e-01 | 0.853 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.491865e-01 | 0.826 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.058717e-01 | 0.686 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.058717e-01 | 0.686 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.058717e-01 | 0.686 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.674941e-01 | 0.776 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.380406e-01 | 0.860 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.311927e-01 | 0.636 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.499482e-01 | 0.824 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.647799e-01 | 0.783 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.574254e-01 | 0.589 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.574254e-01 | 0.589 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.674751e-01 | 0.776 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.298197e-01 | 0.639 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.816262e-01 | 0.741 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.816262e-01 | 0.741 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.007224e-01 | 0.697 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.816262e-01 | 0.741 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.476114e-01 | 0.831 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.799862e-01 | 0.745 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.822377e-01 | 0.739 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.699558e-01 | 0.770 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.699558e-01 | 0.770 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 2.129438e-01 | 0.672 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.593135e-01 | 0.798 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.585693e-01 | 0.587 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.547581e-01 | 0.810 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.574254e-01 | 0.589 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.913832e-01 | 0.718 | 1 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.913832e-01 | 0.718 | 1 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.365129e-01 | 0.865 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.476114e-01 | 0.831 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.404167e-01 | 0.853 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.423515e-01 | 0.847 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.365129e-01 | 0.865 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.783079e-01 | 0.749 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.516511e-01 | 0.599 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.675931e-01 | 0.776 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.614782e-01 | 0.583 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.936046e-01 | 0.713 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.936046e-01 | 0.713 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 2.520028e-01 | 0.599 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.520028e-01 | 0.599 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.574254e-01 | 0.589 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.307718e-01 | 0.883 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.464531e-01 | 0.834 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.401176e-01 | 0.620 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.587894e-01 | 0.799 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.606988e-01 | 0.584 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.780598e-01 | 0.749 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.587894e-01 | 0.799 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.585693e-01 | 0.587 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.365129e-01 | 0.865 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.944377e-01 | 0.711 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.799862e-01 | 0.745 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.909403e-01 | 0.719 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.476114e-01 | 0.831 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.699558e-01 | 0.770 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.574254e-01 | 0.589 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.574254e-01 | 0.589 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 2.516511e-01 | 0.599 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 1.397969e-01 | 0.855 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 1.397969e-01 | 0.855 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.058717e-01 | 0.686 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.936046e-01 | 0.713 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.190723e-01 | 0.659 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.976736e-01 | 0.704 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.083896e-01 | 0.681 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 2.278937e-01 | 0.642 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.264832e-01 | 0.645 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.486856e-01 | 0.828 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.145262e-01 | 0.669 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.145262e-01 | 0.669 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.145262e-01 | 0.669 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 2.221293e-01 | 0.653 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.984362e-01 | 0.702 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.984362e-01 | 0.702 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.984362e-01 | 0.702 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.547581e-01 | 0.810 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.401176e-01 | 0.620 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.816262e-01 | 0.741 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.603070e-01 | 0.795 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.816262e-01 | 0.741 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.083896e-01 | 0.681 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.386767e-01 | 0.622 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.984362e-01 | 0.702 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.967463e-01 | 0.706 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.241896e-01 | 0.649 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.241896e-01 | 0.649 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.929193e-01 | 0.715 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.516511e-01 | 0.599 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.516511e-01 | 0.599 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.449176e-01 | 0.839 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.226547e-01 | 0.652 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 2.372026e-01 | 0.625 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.520028e-01 | 0.599 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.599343e-01 | 0.585 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.479839e-01 | 0.606 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.161875e-01 | 0.665 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.482258e-01 | 0.829 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.469237e-01 | 0.833 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.706989e-01 | 0.768 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.908291e-01 | 0.719 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.908291e-01 | 0.719 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.558090e-01 | 0.807 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.397969e-01 | 0.855 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.695112e-01 | 0.771 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.365129e-01 | 0.865 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.587894e-01 | 0.799 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.516511e-01 | 0.599 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.190723e-01 | 0.659 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.401176e-01 | 0.620 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.476114e-01 | 0.831 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.699558e-01 | 0.770 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.674751e-01 | 0.776 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.372026e-01 | 0.625 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.747996e-01 | 0.757 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.083896e-01 | 0.681 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.747996e-01 | 0.757 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.747996e-01 | 0.757 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.199491e-01 | 0.658 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.911360e-01 | 0.719 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.083896e-01 | 0.681 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.318298e-01 | 0.880 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.173288e-01 | 0.663 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.371835e-01 | 0.625 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.516511e-01 | 0.599 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.752317e-01 | 0.756 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.576555e-01 | 0.802 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.699558e-01 | 0.770 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.911360e-01 | 0.719 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.365129e-01 | 0.865 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.516511e-01 | 0.599 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.030860e-01 | 0.692 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.598091e-01 | 0.796 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.494049e-01 | 0.826 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.380406e-01 | 0.860 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.774563e-01 | 0.751 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.598091e-01 | 0.796 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.547581e-01 | 0.810 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.585693e-01 | 0.587 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.752317e-01 | 0.756 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.491865e-01 | 0.826 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.618825e-01 | 0.582 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.629116e-01 | 0.580 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.644978e-01 | 0.578 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.670246e-01 | 0.573 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.670246e-01 | 0.573 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.670246e-01 | 0.573 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.670246e-01 | 0.573 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.670246e-01 | 0.573 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.671837e-01 | 0.573 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.682869e-01 | 0.571 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.690693e-01 | 0.570 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.719331e-01 | 0.566 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.733566e-01 | 0.563 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 2.752783e-01 | 0.560 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.752783e-01 | 0.560 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.752783e-01 | 0.560 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.752783e-01 | 0.560 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 2.752783e-01 | 0.560 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 2.752783e-01 | 0.560 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.761333e-01 | 0.559 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.761333e-01 | 0.559 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.761333e-01 | 0.559 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.788287e-01 | 0.555 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.788287e-01 | 0.555 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.788287e-01 | 0.555 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.789829e-01 | 0.554 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.796583e-01 | 0.553 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 2.812619e-01 | 0.551 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.812619e-01 | 0.551 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.812619e-01 | 0.551 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.812619e-01 | 0.551 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.812619e-01 | 0.551 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.812619e-01 | 0.551 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.822376e-01 | 0.549 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.830649e-01 | 0.548 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.836241e-01 | 0.547 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.938832e-01 | 0.532 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.947875e-01 | 0.530 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.969322e-01 | 0.527 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.976115e-01 | 0.526 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.981163e-01 | 0.526 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.981163e-01 | 0.526 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.988936e-01 | 0.524 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.047939e-01 | 0.516 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.047939e-01 | 0.516 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 3.047939e-01 | 0.516 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.047939e-01 | 0.516 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.048701e-01 | 0.516 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.048701e-01 | 0.516 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.096749e-01 | 0.509 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.104471e-01 | 0.508 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.107715e-01 | 0.508 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.107715e-01 | 0.508 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.107715e-01 | 0.508 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.107715e-01 | 0.508 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.107715e-01 | 0.508 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.107715e-01 | 0.508 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.107715e-01 | 0.508 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.117728e-01 | 0.506 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.119533e-01 | 0.506 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.131166e-01 | 0.504 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.221983e-01 | 0.492 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.265869e-01 | 0.486 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.297577e-01 | 0.482 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.297577e-01 | 0.482 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 3.313349e-01 | 0.480 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.313349e-01 | 0.480 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.313349e-01 | 0.480 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.313349e-01 | 0.480 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.313349e-01 | 0.480 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.313349e-01 | 0.480 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.349646e-01 | 0.475 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.357434e-01 | 0.474 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.399119e-01 | 0.469 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.399119e-01 | 0.469 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.400186e-01 | 0.468 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.400186e-01 | 0.468 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.400186e-01 | 0.468 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.400186e-01 | 0.468 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.400186e-01 | 0.468 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.444046e-01 | 0.463 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.444046e-01 | 0.463 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.444046e-01 | 0.463 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.444046e-01 | 0.463 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 3.468427e-01 | 0.460 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.483712e-01 | 0.458 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.483712e-01 | 0.458 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.539930e-01 | 0.451 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.579945e-01 | 0.446 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.586812e-01 | 0.445 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 3.601314e-01 | 0.444 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.603577e-01 | 0.443 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.628211e-01 | 0.440 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.681153e-01 | 0.434 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.688674e-01 | 0.433 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.688674e-01 | 0.433 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.688674e-01 | 0.433 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.688674e-01 | 0.433 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.688674e-01 | 0.433 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.688674e-01 | 0.433 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.688674e-01 | 0.433 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.691889e-01 | 0.433 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.740759e-01 | 0.427 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.758775e-01 | 0.425 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.775404e-01 | 0.423 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.779399e-01 | 0.423 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.830587e-01 | 0.417 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.830587e-01 | 0.417 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.830587e-01 | 0.417 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.830587e-01 | 0.417 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.830587e-01 | 0.417 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.830587e-01 | 0.417 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.830587e-01 | 0.417 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.838688e-01 | 0.416 | 1 | 1 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.838688e-01 | 0.416 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.861658e-01 | 0.413 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.871781e-01 | 0.412 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.895510e-01 | 0.409 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 3.895510e-01 | 0.409 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.916169e-01 | 0.407 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.916169e-01 | 0.407 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.931657e-01 | 0.405 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.972047e-01 | 0.401 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.972047e-01 | 0.401 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.972047e-01 | 0.401 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.972047e-01 | 0.401 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.972047e-01 | 0.401 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.995156e-01 | 0.398 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.018293e-01 | 0.396 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.045598e-01 | 0.393 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.073251e-01 | 0.390 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.130297e-01 | 0.384 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.130297e-01 | 0.384 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.138461e-01 | 0.383 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.198705e-01 | 0.377 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.218569e-01 | 0.375 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.230921e-01 | 0.374 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.238520e-01 | 0.373 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.249371e-01 | 0.372 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.249371e-01 | 0.372 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.249371e-01 | 0.372 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.250780e-01 | 0.372 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 4.307843e-01 | 0.366 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 4.307843e-01 | 0.366 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.307843e-01 | 0.366 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.307843e-01 | 0.366 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.307843e-01 | 0.366 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.307843e-01 | 0.366 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.307843e-01 | 0.366 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.307843e-01 | 0.366 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.307843e-01 | 0.366 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.307843e-01 | 0.366 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.307843e-01 | 0.366 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.307843e-01 | 0.366 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.341645e-01 | 0.362 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.367136e-01 | 0.360 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.374268e-01 | 0.359 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.385542e-01 | 0.358 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.385542e-01 | 0.358 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.463243e-01 | 0.350 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.519886e-01 | 0.345 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.519886e-01 | 0.345 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.519886e-01 | 0.345 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.519886e-01 | 0.345 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.550104e-01 | 0.342 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.550104e-01 | 0.342 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.591381e-01 | 0.338 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.600372e-01 | 0.337 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.639500e-01 | 0.334 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.639500e-01 | 0.334 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.666721e-01 | 0.331 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.748205e-01 | 0.323 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.748205e-01 | 0.323 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.748205e-01 | 0.323 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.748205e-01 | 0.323 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 4.748205e-01 | 0.323 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.748205e-01 | 0.323 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 4.748205e-01 | 0.323 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.748205e-01 | 0.323 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.748205e-01 | 0.323 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 4.748205e-01 | 0.323 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.755271e-01 | 0.323 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 4.782987e-01 | 0.320 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.782987e-01 | 0.320 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.782987e-01 | 0.320 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.782987e-01 | 0.320 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.851462e-01 | 0.314 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.940868e-01 | 0.306 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.956789e-01 | 0.305 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.956789e-01 | 0.305 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.038203e-01 | 0.298 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.038203e-01 | 0.298 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.038203e-01 | 0.298 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.038203e-01 | 0.298 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.038203e-01 | 0.298 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.038203e-01 | 0.298 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.038203e-01 | 0.298 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.065086e-01 | 0.295 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.065086e-01 | 0.295 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 5.085346e-01 | 0.294 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.145668e-01 | 0.289 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.154524e-01 | 0.288 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.154524e-01 | 0.288 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.154524e-01 | 0.288 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.154524e-01 | 0.288 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.154524e-01 | 0.288 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.154524e-01 | 0.288 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.154524e-01 | 0.288 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.154524e-01 | 0.288 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.154524e-01 | 0.288 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.154524e-01 | 0.288 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.154524e-01 | 0.288 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.154524e-01 | 0.288 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.154524e-01 | 0.288 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.154524e-01 | 0.288 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.196002e-01 | 0.284 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.285178e-01 | 0.277 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.285178e-01 | 0.277 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.285178e-01 | 0.277 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.285178e-01 | 0.277 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.285178e-01 | 0.277 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.292719e-01 | 0.276 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.347680e-01 | 0.272 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.347680e-01 | 0.272 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.396038e-01 | 0.268 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.437755e-01 | 0.265 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.466526e-01 | 0.262 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.523661e-01 | 0.258 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.523661e-01 | 0.258 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.523661e-01 | 0.258 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.523661e-01 | 0.258 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.523661e-01 | 0.258 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.523661e-01 | 0.258 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.523661e-01 | 0.258 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.529429e-01 | 0.257 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.529429e-01 | 0.257 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 5.529429e-01 | 0.257 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.529429e-01 | 0.257 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.529429e-01 | 0.257 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.529429e-01 | 0.257 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.529429e-01 | 0.257 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.529429e-01 | 0.257 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.529429e-01 | 0.257 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.529429e-01 | 0.257 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.529429e-01 | 0.257 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.531469e-01 | 0.257 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.565290e-01 | 0.255 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.600998e-01 | 0.252 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.629308e-01 | 0.250 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.629308e-01 | 0.250 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.715322e-01 | 0.243 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.715322e-01 | 0.243 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 5.720785e-01 | 0.243 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.753487e-01 | 0.240 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.753487e-01 | 0.240 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.753487e-01 | 0.240 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.780670e-01 | 0.238 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.828604e-01 | 0.234 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.870223e-01 | 0.231 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 5.875348e-01 | 0.231 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.875348e-01 | 0.231 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.875348e-01 | 0.231 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 5.875348e-01 | 0.231 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.875348e-01 | 0.231 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 5.875348e-01 | 0.231 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 5.875348e-01 | 0.231 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.875348e-01 | 0.231 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.875348e-01 | 0.231 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.875348e-01 | 0.231 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.883201e-01 | 0.230 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.900211e-01 | 0.229 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.900211e-01 | 0.229 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.922130e-01 | 0.228 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.974567e-01 | 0.224 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.974567e-01 | 0.224 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.974567e-01 | 0.224 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.974567e-01 | 0.224 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.974567e-01 | 0.224 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.974567e-01 | 0.224 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.974567e-01 | 0.224 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.974567e-01 | 0.224 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.974567e-01 | 0.224 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.978779e-01 | 0.223 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 6.021805e-01 | 0.220 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.074710e-01 | 0.216 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.074710e-01 | 0.216 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.074710e-01 | 0.216 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 6.122485e-01 | 0.213 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.186881e-01 | 0.209 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.186881e-01 | 0.209 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.194519e-01 | 0.208 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.194519e-01 | 0.208 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.194519e-01 | 0.208 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.194519e-01 | 0.208 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.194519e-01 | 0.208 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.194519e-01 | 0.208 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.194519e-01 | 0.208 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.194519e-01 | 0.208 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.194519e-01 | 0.208 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 6.194519e-01 | 0.208 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.206868e-01 | 0.207 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.244188e-01 | 0.205 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.244188e-01 | 0.205 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.259193e-01 | 0.203 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.259193e-01 | 0.203 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.271667e-01 | 0.203 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.390459e-01 | 0.194 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.390459e-01 | 0.194 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.390459e-01 | 0.194 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.390459e-01 | 0.194 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.390459e-01 | 0.194 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 6.408577e-01 | 0.193 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.489011e-01 | 0.188 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.489011e-01 | 0.188 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.489011e-01 | 0.188 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.489011e-01 | 0.188 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.489011e-01 | 0.188 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.489011e-01 | 0.188 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.489011e-01 | 0.188 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.489011e-01 | 0.188 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.489011e-01 | 0.188 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.489011e-01 | 0.188 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.512312e-01 | 0.186 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.567366e-01 | 0.183 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.567834e-01 | 0.183 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.567834e-01 | 0.183 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.585383e-01 | 0.181 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.585383e-01 | 0.181 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.585383e-01 | 0.181 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.585383e-01 | 0.181 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.593233e-01 | 0.181 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.653495e-01 | 0.177 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.690514e-01 | 0.175 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.721940e-01 | 0.173 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.721940e-01 | 0.173 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.721940e-01 | 0.173 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.721940e-01 | 0.173 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.721940e-01 | 0.173 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.727067e-01 | 0.172 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.760729e-01 | 0.170 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.760729e-01 | 0.170 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.760729e-01 | 0.170 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 6.760729e-01 | 0.170 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 6.760729e-01 | 0.170 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 6.760729e-01 | 0.170 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.771772e-01 | 0.169 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.771772e-01 | 0.169 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.771772e-01 | 0.169 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.857222e-01 | 0.164 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.857222e-01 | 0.164 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.870990e-01 | 0.163 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.898182e-01 | 0.161 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.984824e-01 | 0.156 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.011433e-01 | 0.154 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.011433e-01 | 0.154 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.011433e-01 | 0.154 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.011433e-01 | 0.154 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.011433e-01 | 0.154 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.011433e-01 | 0.154 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.011433e-01 | 0.154 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.011433e-01 | 0.154 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.011433e-01 | 0.154 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.014721e-01 | 0.154 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.014721e-01 | 0.154 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.119587e-01 | 0.148 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.119587e-01 | 0.148 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.119587e-01 | 0.148 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.119587e-01 | 0.148 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.119587e-01 | 0.148 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.242748e-01 | 0.140 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.242748e-01 | 0.140 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.242748e-01 | 0.140 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.242748e-01 | 0.140 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.242748e-01 | 0.140 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.242748e-01 | 0.140 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.242748e-01 | 0.140 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.242748e-01 | 0.140 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.242748e-01 | 0.140 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.242748e-01 | 0.140 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.242748e-01 | 0.140 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.259539e-01 | 0.139 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 7.281397e-01 | 0.138 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.287136e-01 | 0.137 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.287136e-01 | 0.137 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.287136e-01 | 0.137 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.287136e-01 | 0.137 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.287136e-01 | 0.137 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 7.308947e-01 | 0.136 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.435429e-01 | 0.129 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.435429e-01 | 0.129 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.456172e-01 | 0.127 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 7.456172e-01 | 0.127 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.456172e-01 | 0.127 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.456172e-01 | 0.127 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.456172e-01 | 0.127 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.456172e-01 | 0.127 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.456172e-01 | 0.127 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.456172e-01 | 0.127 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.456172e-01 | 0.127 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.560782e-01 | 0.121 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.560782e-01 | 0.121 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.581918e-01 | 0.120 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.581918e-01 | 0.120 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.581918e-01 | 0.120 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.581918e-01 | 0.120 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.653087e-01 | 0.116 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.653087e-01 | 0.116 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 7.653087e-01 | 0.116 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.653087e-01 | 0.116 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.653087e-01 | 0.116 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.653087e-01 | 0.116 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.653087e-01 | 0.116 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.653087e-01 | 0.116 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.653087e-01 | 0.116 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 7.653087e-01 | 0.116 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.658615e-01 | 0.116 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.665327e-01 | 0.115 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.721109e-01 | 0.112 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.721109e-01 | 0.112 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.721109e-01 | 0.112 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.721109e-01 | 0.112 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.721109e-01 | 0.112 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.756648e-01 | 0.110 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.791536e-01 | 0.108 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.791536e-01 | 0.108 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.832078e-01 | 0.106 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.834771e-01 | 0.106 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 7.834771e-01 | 0.106 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.834771e-01 | 0.106 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 7.834771e-01 | 0.106 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.834771e-01 | 0.106 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.834771e-01 | 0.106 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 7.834771e-01 | 0.106 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 7.834771e-01 | 0.106 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.834771e-01 | 0.106 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.834771e-01 | 0.106 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.848930e-01 | 0.105 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.853252e-01 | 0.105 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.853252e-01 | 0.105 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.853252e-01 | 0.105 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.853252e-01 | 0.105 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.856000e-01 | 0.105 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.882490e-01 | 0.103 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.957958e-01 | 0.099 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.964865e-01 | 0.099 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.978606e-01 | 0.098 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.987596e-01 | 0.098 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.987596e-01 | 0.098 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.996535e-01 | 0.097 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.002399e-01 | 0.097 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.002399e-01 | 0.097 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.002399e-01 | 0.097 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.002399e-01 | 0.097 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.002399e-01 | 0.097 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.002399e-01 | 0.097 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.002399e-01 | 0.097 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.002399e-01 | 0.097 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.002399e-01 | 0.097 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.002399e-01 | 0.097 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.002399e-01 | 0.097 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.002399e-01 | 0.097 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.002399e-01 | 0.097 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.002399e-01 | 0.097 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.066359e-01 | 0.093 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.088297e-01 | 0.092 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.088297e-01 | 0.092 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.088297e-01 | 0.092 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.097428e-01 | 0.092 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.136110e-01 | 0.090 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.136110e-01 | 0.090 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.157060e-01 | 0.088 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.157060e-01 | 0.088 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.157060e-01 | 0.088 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.157060e-01 | 0.088 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.157060e-01 | 0.088 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.157060e-01 | 0.088 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.157060e-01 | 0.088 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.157060e-01 | 0.088 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.157060e-01 | 0.088 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.157060e-01 | 0.088 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.209978e-01 | 0.086 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.209978e-01 | 0.086 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.209978e-01 | 0.086 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.209978e-01 | 0.086 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.276952e-01 | 0.082 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.279246e-01 | 0.082 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.280423e-01 | 0.082 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.280423e-01 | 0.082 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.299754e-01 | 0.081 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.299754e-01 | 0.081 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.299754e-01 | 0.081 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.301320e-01 | 0.081 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.312989e-01 | 0.080 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.316515e-01 | 0.080 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.316515e-01 | 0.080 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.316515e-01 | 0.080 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.375611e-01 | 0.077 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.417295e-01 | 0.075 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.417295e-01 | 0.075 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.417295e-01 | 0.075 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.421005e-01 | 0.075 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.431408e-01 | 0.074 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.431408e-01 | 0.074 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.431408e-01 | 0.074 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.431408e-01 | 0.074 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 8.431408e-01 | 0.074 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.431408e-01 | 0.074 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.431408e-01 | 0.074 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.431408e-01 | 0.074 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.431408e-01 | 0.074 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.431408e-01 | 0.074 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 8.431408e-01 | 0.074 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.431408e-01 | 0.074 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.477494e-01 | 0.072 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.526127e-01 | 0.069 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.529054e-01 | 0.069 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.552803e-01 | 0.068 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.552875e-01 | 0.068 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 8.552875e-01 | 0.068 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.552875e-01 | 0.068 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.552875e-01 | 0.068 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.552875e-01 | 0.068 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.573750e-01 | 0.067 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.602590e-01 | 0.065 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.602590e-01 | 0.065 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 8.664943e-01 | 0.062 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.664943e-01 | 0.062 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.664943e-01 | 0.062 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.664943e-01 | 0.062 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.664943e-01 | 0.062 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.685395e-01 | 0.061 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.687595e-01 | 0.061 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.737566e-01 | 0.059 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.767823e-01 | 0.057 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.768338e-01 | 0.057 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 8.768338e-01 | 0.057 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.768338e-01 | 0.057 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.768338e-01 | 0.057 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.768338e-01 | 0.057 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.768338e-01 | 0.057 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.768338e-01 | 0.057 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.768338e-01 | 0.057 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.768338e-01 | 0.057 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 8.768338e-01 | 0.057 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 8.768338e-01 | 0.057 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.768338e-01 | 0.057 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.789450e-01 | 0.056 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.801715e-01 | 0.055 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.843502e-01 | 0.053 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.843502e-01 | 0.053 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.843502e-01 | 0.053 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.863731e-01 | 0.052 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.863731e-01 | 0.052 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.863731e-01 | 0.052 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.863731e-01 | 0.052 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 8.863731e-01 | 0.052 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.863731e-01 | 0.052 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.877160e-01 | 0.052 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.951741e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.951741e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.951741e-01 | 0.048 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.951741e-01 | 0.048 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.951741e-01 | 0.048 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.969945e-01 | 0.047 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.994391e-01 | 0.046 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.997433e-01 | 0.046 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.032362e-01 | 0.044 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.032939e-01 | 0.044 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.032939e-01 | 0.044 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.032939e-01 | 0.044 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.032939e-01 | 0.044 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.032939e-01 | 0.044 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.032939e-01 | 0.044 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.032939e-01 | 0.044 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.045447e-01 | 0.044 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.052003e-01 | 0.043 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.052003e-01 | 0.043 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.065718e-01 | 0.043 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.107852e-01 | 0.041 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.107852e-01 | 0.041 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.107852e-01 | 0.041 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.107852e-01 | 0.041 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.107852e-01 | 0.041 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.107852e-01 | 0.041 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.107852e-01 | 0.041 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.107852e-01 | 0.041 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.107852e-01 | 0.041 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.107852e-01 | 0.041 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.153149e-01 | 0.038 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.153149e-01 | 0.038 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.165592e-01 | 0.038 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.176966e-01 | 0.037 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.176966e-01 | 0.037 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.176966e-01 | 0.037 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.176966e-01 | 0.037 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.176966e-01 | 0.037 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.176966e-01 | 0.037 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.176966e-01 | 0.037 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.176966e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.176966e-01 | 0.037 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.176966e-01 | 0.037 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.176966e-01 | 0.037 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.188982e-01 | 0.037 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.199947e-01 | 0.036 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.214043e-01 | 0.036 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.240730e-01 | 0.034 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.240730e-01 | 0.034 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.240730e-01 | 0.034 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.240730e-01 | 0.034 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.240730e-01 | 0.034 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.240730e-01 | 0.034 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.240730e-01 | 0.034 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.244370e-01 | 0.034 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.263713e-01 | 0.033 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.263713e-01 | 0.033 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.286522e-01 | 0.032 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.299557e-01 | 0.032 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.299557e-01 | 0.032 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.299557e-01 | 0.032 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.299557e-01 | 0.032 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.299557e-01 | 0.032 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.299557e-01 | 0.032 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.299557e-01 | 0.032 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.299557e-01 | 0.032 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.310690e-01 | 0.031 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.341591e-01 | 0.030 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.353830e-01 | 0.029 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.353830e-01 | 0.029 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.364411e-01 | 0.029 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.374774e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.403900e-01 | 0.027 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.403900e-01 | 0.027 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.434239e-01 | 0.025 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.450093e-01 | 0.025 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.450093e-01 | 0.025 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.450093e-01 | 0.025 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.450093e-01 | 0.025 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.467315e-01 | 0.024 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.470590e-01 | 0.024 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.478734e-01 | 0.023 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.487126e-01 | 0.023 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.492710e-01 | 0.023 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.492710e-01 | 0.023 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.492710e-01 | 0.023 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.504180e-01 | 0.022 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.504180e-01 | 0.022 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.532025e-01 | 0.021 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.532025e-01 | 0.021 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.566748e-01 | 0.019 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.568296e-01 | 0.019 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.568296e-01 | 0.019 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.594139e-01 | 0.018 | 1 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.597283e-01 | 0.018 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.601758e-01 | 0.018 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.601758e-01 | 0.018 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.601758e-01 | 0.018 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.606104e-01 | 0.017 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.621306e-01 | 0.017 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.621306e-01 | 0.017 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.622230e-01 | 0.017 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.632628e-01 | 0.016 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.632628e-01 | 0.016 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.632628e-01 | 0.016 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.632628e-01 | 0.016 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.632628e-01 | 0.016 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.636441e-01 | 0.016 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.646048e-01 | 0.016 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.655778e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.661107e-01 | 0.015 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.661107e-01 | 0.015 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.674617e-01 | 0.014 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.688689e-01 | 0.014 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.688689e-01 | 0.014 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.708999e-01 | 0.013 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.711617e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.711617e-01 | 0.013 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.721534e-01 | 0.012 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.724928e-01 | 0.012 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.724928e-01 | 0.012 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.733976e-01 | 0.012 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.733976e-01 | 0.012 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.754604e-01 | 0.011 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.773632e-01 | 0.010 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.775843e-01 | 0.010 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.791187e-01 | 0.009 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.791187e-01 | 0.009 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.798604e-01 | 0.009 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.807381e-01 | 0.008 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.807381e-01 | 0.008 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.807381e-01 | 0.008 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.807381e-01 | 0.008 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.822320e-01 | 0.008 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.822320e-01 | 0.008 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.822320e-01 | 0.008 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.848814e-01 | 0.007 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.848814e-01 | 0.007 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.848814e-01 | 0.007 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.848814e-01 | 0.007 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.853611e-01 | 0.006 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.860964e-01 | 0.006 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.867354e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.867354e-01 | 0.006 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.867354e-01 | 0.006 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.871360e-01 | 0.006 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.873951e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.873951e-01 | 0.006 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.881340e-01 | 0.005 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.882466e-01 | 0.005 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.890547e-01 | 0.005 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.890547e-01 | 0.005 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.897151e-01 | 0.004 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.899039e-01 | 0.004 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.904781e-01 | 0.004 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.906588e-01 | 0.004 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.906873e-01 | 0.004 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.914100e-01 | 0.004 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.914100e-01 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.914100e-01 | 0.004 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.915295e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.926915e-01 | 0.003 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.937820e-01 | 0.003 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.942646e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.943614e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.947099e-01 | 0.002 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.949466e-01 | 0.002 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.951205e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.954992e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.954992e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.954994e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.954994e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.958488e-01 | 0.002 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.958488e-01 | 0.002 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.958488e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.958488e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.958488e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.961711e-01 | 0.002 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.964684e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.967427e-01 | 0.001 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.968891e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.969518e-01 | 0.001 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.970475e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.976427e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.976427e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.977156e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.978158e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.978258e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.978749e-01 | 0.001 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.982902e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.982942e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.982942e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.982942e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.984267e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.985562e-01 | 0.001 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.986617e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.986617e-01 | 0.001 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.989501e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.989594e-01 | 0.000 | 1 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.990317e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.992404e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.994795e-01 | 0.000 | 1 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.996025e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.996296e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.996593e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.998082e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.998496e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.998603e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998613e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998650e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.998657e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.998929e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.999076e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999173e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999276e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999424e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999426e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999476e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999517e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999614e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999651e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999694e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999754e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999754e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999770e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999793e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999842e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999845e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999845e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999868e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999882e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999912e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999931e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999931e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999950e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999972e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999980e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999981e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999983e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999987e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999989e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999993e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999994e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999996e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |